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ABSTRACT	  
Epigenetics has been defined by Goldberg et al. [1]  as the study of heritable changes 
in gene expression or cellular phenotype which arises without changes in the DNA 
sequence. Post-translational histone modification and exchange of histone variants are 
two important epigenetic mechanisms. Histones and histone variants have been shown 
to be involved in many cellular events, for example they largely contribute to 
regulation of gene expression.  
Chromatin immunoprecipitation (ChIP) is a versatile tool to study protein-DNA 
interactions in general and the location of post-translational histone modifications in 
particular. We used this approach to investigate three post-translational histone 
modifications and a histone variant, during spermatogenesis where global changes in 
the epigenome are known to occur.  
We assessed occupancy of the histone modifications H3K4me3, H3K9me2 and 
H3K27me3 and the testis specific histone variant TH2B on regulatory sequences of 
genes encoding histone modifying enzymes, chromatin remodelers and genes 
important to early embryo development in mice pachytene spermatocytes (PCS) and 
round spermatids (RS).  
The objective of this thesis was to initiate the investigation of the role of TH2B and 
the bivalent marks H3K27me3 and H3K4me3 in spermatogenesis. This study 
revealed that the facultative repressive mark H3K9me2 and TH2B showed strong 
correlation at gene regulatory sequences in PCS and RS cells. Moreover, TH2B 
correlated inversely with the activating mark H3K4me3. This may indicate that TH2B 
plays a role as a testis specific repressive histone variant. Additionally, we observed 
significant levels of the bivalent marks H3K4me3 and H3K27me3 on the Hoxd4 and 
Oct4 promoter in PCS and RS. On a speculative note, this could perhaps be 
suggestive of preprogramming for expression in early embryo development. 
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1 INTRODUCTION	  
 
1.1 Organization	  of	  the	  genome	  
Nuclear DNA in eukaryotes is linear and organized into chromosomes, each packaged 
into a compact structure called chromatin. The fundamental unit of chromatin is a 
structure called nucleosome (Fig. 1a). A nucleosome consists of 145-147 base pairs 
(bp) of DNA [2] wrapped around two copies of the core histones; histone 2A (H2A), 
H2B, H3 and H4. The nucleosome is linked together by a stretch of 10-80 bp of linker 
DNA that is usually associated with histone H1 in higher eukaryotes. Histones are 
involved in regulating many cellular events such as transcription, DNA replication, 
recombination and repair. They primarily act either to ensure tight DNA packaging 
making DNA largely inaccessible, or to relax the chromatin structure making the 
chromatin less compact and the DNA more accessible [3]. 
 
 
Figure	  1:	  a)	  The	  atomic	  structure	  of	  the	  nucleosome.	  The	  two	  DNA	  strands	  are	  shown	  in	  pale	  and	  dark	  blue,	  completing	  1.65	  turns	  around	  an	  octamer	  of	  core	  histones	  to	  make	  a	  nucleosome	  particle	  with	  a	  disc-­‐like	  structure.	  Histone	  H2A	  is	  colored	  in	  red,	  H2B	  in	  pink,	  H3	  in	  green	  and	  H4	  in	  yellow.	  From	  Khorasanizadeh,	  2004.	  b)	  Organization	  of	  chromatin	  in	  the	  interphase	  nucleus.	  The	  DNA	  double	  helix	  wraps	  around	  an	  octamer	  of	  core	  histones	  to	  form	  a	  nucleosome.	  Nucleosomes	  are	  spaced	  by	  linker	  DNA	  which	  harbors	  the	  linker	  histone	  H1.	  From	  Klug	  and	  Cummings,	  1997.	  
 
Chromatin (Fig. 1b) is a dynamic structure and the density of chromatin packaging 
varies throughout the cell cycle. In general chromatin can be classified into two major 
forms; active euchromatin and silenced heterochromatin. Active euchromatin is found 
in the gene-rich transcriptionally active portion of the genome, where DNA is bound 
a b 
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loosely to histones [4]. In silenced heterochromatin, DNA and histones are tightly 
associated [4], and the genes within it is repressed. Heterochromatin can further be 
classified as facultative heterochromatin, rich in non-coding repetitive DNA 
sequences and constitutive heterochromatin which is euchromatin being packaged and 
repressed during cellular development [5].  
The number of protein encoding genes in human are to date estimated to 20,000-
25,000. Protein coding genes consist of one or more exons interspersed between 
introns that is non-protein coding sequences, and at their 5`and 3`ends they have 
untranslated regions (UTRs) [6]. A proximal promoter that facilitate transcription is 
located upstream of the transcriptional start site and additional regulatory sequences 
may be found up- or downstream of the gene [7].  
Transcription of protein encoding genes is carried out by RNA polymerase II that 
needs co-activators to get access to the DNA template. The co-activators may be 
histone-modifying enzymes that marks chromatin for activation by covalent coupling 
of chemical groups, such as acetyl or methyl groups to amino acids on NH2-terminal 
histone tails [3]. These marks can recruit ATP-dependent chromatin remodeling 
enzymes that further alter nucleosome conformation to provide an accessible DNA 
template [8]. Conversely, compaction of chromatin make genes inaccessible for 
transcription by combined action of co-repressors. By directly binding to DNA or 
regulatory elements, transcription factors can act as repressors or activators and thus 
impart to time-, cell- and tissue- specifity of transcription [9]. 
Many genes encode RNAs that are not translated into protein. Among others are a 
diverse group of small RNAs involved in regulating mRNA stability, transcription, 
genome integrity and chromatin structure, and some of them are shown to have 
important roles in the formation of condensed chromatin [10-12].  
 
1.2 Epigenetic	  modifications	  
Epigenetics can be defined as the study of heritable changes in gene expression or 
cellular phenotype that arises without changes in the DNA sequence [1]. Epigenetic 
mechanisms such as post-translational histone modifications, DNA methylation, 
ATP-dependent chromatin remodeling or exchange of histones and histone variants 
[13] influence the connection between DNA and histones leading to transcriptionally 
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active or inactive genes [14] and thus these mechanisms are involved in regulating 
gene expression. 
1.2.1 Post-­‐translational	  histone	  modifications	  
Core histones are small basic proteins and consist of a globular domain and a flexible 
histone tail that protrudes from the nucleosome [4]. Histones possess a large number 
of modified residues (Fig. 2), especially in their N-terminal tail [15]. These 
modifications include acetylation, methylation, ubiquitylation and sumoylation of 
lysine (K) residues; methylation and deamination of arginines (R); phosphorylation of 
serines (S) and threonines (T); ADP ribosylation of glutamates (E), and proline (P) 
isomerization [15]. These modified residues may affect chromatin structure by 
altering inter- and intra-nucleosomal interactions and/or recruit non-histone proteins 
[16]. The histone modifications can physically directly influence chromatin structure 
or they can regulate recruitment of proteins onto DNA (nucleosome-remodelling 
enzymes, transcription factors, histone-modifying enzymes and heterochromatin-
associated proteins).  
 
 
Figure	  2:	  Histone	  modifications.	  Some	  arginine	  residues	  (R)	  can	  be	  methylated.	  Some	  lysine	  residues	  (K)	  can	  be	  either	  acetylated,	  methylated	  or	  ubiquitylated.	  Some	  serine	  residues	  (S)	  can	  be	  phosphorylated.	  	  From	  Zamudio	  N	  M	  et	  al.	  2008	  [14]	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The acetylation of lysines is mediated by histone acetyltransferases (HATs) and 
acetylated lysines are deacetylated by histone deacetylaces (HDACs). The HATs 
catalyse the transfer of an acetyl group to the ε-amino group of lysine side chains and 
thus neutralize the basic charge of the lysines [17]. This leads to weakened interaction 
between histones and DNA, and by this histone acetylation is generally associated 
with transcriptionally active chromatin. Deacetylation by HDACs reverses lysine 
acetylation and is associated with gene repression [14, 17]. This is an example of how 
histone modifications directly influence chromatin structure, but histone acetylation 
may also regulate recruitment of proteins onto DNA.  
Histone phosphorylation is mostly related to transcriptional activation and takes place 
on several residues of all the histones. Phosphorylation may also lead to gene 
silencing, for instance phosphorylation of H2AX forming γ-H2AX during meiosis 
[18].  
One of the most common histone modifications is methylation which mainly occurs 
on the side chains of lysines and arginines [14, 17]. Lysine residues may be mono-, 
di- and trimethylated. Arginines have the ability to be mono-methylated or 
dimethylated either symmetrically or asymmetrically [19]. Histone methylation does 
not change the charge of the histone protein, instead it function in regulating 
recruitment of effector proteins that elicit functional outcome. The effector proteins 
can bind to methylated residues via conserved domains, and methylation is 
recognized by chromo-like (chromo, tudor) domain and Plant Homeo Domain (PHD). 
Histone methyltransferases mediate histone methylation while histone demethylases 
remove methyl groups. Depending on the modified residue, histone methylation is 
involved in both gene activation and silencing. Methylation of lysine 4 of H3 (H3K4) 
is related to active transcription, while for instance methylated H3 lysine 9 (H3K9) 
and H3 lysine 27 (H3K27) are bound by Heterochromatin Protein 1 (HP1) and 
polycomb, respectively and form compact chromatin [20, 21]. The vast majority of 
histone methyl lysine transferases (HKMTs) methylate lysines within the N-terminal 
tails, and they share a Su(var), Enhancer of zest, and Trithorax (SET) domain that 
harbor the enzymatic activity [17, 19]. The first identified lysine demethylase was 
termed lysine-specific demethylase 1 (LSD1), which uses flavin adenine dinucleotide 
(FAD) as a co-factor and can de-methylate mono and di methylated lysine substrates. 
Another class of de-methylases belong to a family which contain a Jumonji-C (Jmjc) 
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domain that harbor the enzymatic activity. These enzymes can target removal of all 
three histone lysine methylation states [19].  
1.2.2 DNA	  methylation	  
DNA methylation is an epigenetic modification that predominantly occurs at the 5-
position of a cytosine-phosphate-guanine (CpG) dinucleotide [22]. DNA methylation 
is performed by a family of proteins named DNA methyltransferases (DNMTs) [23]. 
Some of the DNMT3s interplay to mediate de novo methylation in mammalian sperm 
[24], while DNMT1 work as a maintenance enzyme and preserve previously 
established methylation patterns during DNA replication [25]. DNA methylation is 
implicated to have functions in tissue-specific gene expression, cell differentiation, 
development of gametes and developing embryo such as genomic imprinting, X 
chromosome inactivation, and retrotransposon silencing [26] among others. 
Mechanistically, a methylated cytosine base can function to affect recruitment of 
regulatory proteins [20] or it can affect nucleosome positioning by impacting the 
affinity for core histones. In the former case, the methyl mark can pass on a binding 
site for methyl-binding domain proteins MBD1, 2, 3, 4 and MeCP2 and thus mediate 
transcriptional repression [20, 27]. An example is the silencing of transcription when 
MeCP2 recruit HDAC and H3K9 HMT activities [28].  
 
 
1.3 Spermatogenesis	  
The germ line is rapidly being reprogrammed from spermatogonia stem cells to 
mature spermatozoa and it therefore offers an attractive system for studying 
reprogramming of epigenetic gene regulation in vivo. During spermatogenesis, global 
changes in the epigenome occur. Spermatogenesis (Fig. 3) constitute of three major 
steps: pre-meiotic, meiotic and post-meiotic [29]. Spermatogonia are derived from 
primordial germ cells that during fetal life were specified to give rise to the germline 
[30]. The diploid spermatogonia divides mitotically to ensure a generation of self-
renewing spermatogonia and to produce primary diploid spermatocytes [29]. Primary 
diploid (2N) spermatocytes enter the first meiotic division to yield two secondary 
spermatocytes that are haploid (N). The secondary spermatocytes undergo a second 
meiotic division to end up with four haploid spermatids [31]. Further post-meiotic 
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round spermatids develop into mature spermatozoa through a metamorphic process 
[32].  
Developing primary spermatocytes spend over 90% of the time for meiosis in 
prophase 1 [33]. Prophase 1 can be divided into four stages: leptotene, zygotene, 
pachytene and diplotene. In the leptotene stage chromosomes start condensing and 
double-strand breaks (DSBs) that are essential for homologous recombination start to 
form [34]. During the zygotene stage, sister chromatids pair and synaptonemal 
complexes (SCs) that are proteinaceous structures are formed [35]. The SYCP3 
protein is a component in the SCs. At the pachytene stage synapsis is completed and 
homologous recombination occurs. In the diplotene stage the synaptonemal complex 
breaks down and the chromosome separation is initiated [36]. 
 
Figure	  3:	  The	  development	  from	  spermatogonium	  to	  mature	  spermatozoan	  (spermatid)	  through	  spermatogenesis.	  MI,	  meiose	  I;	  MII,	  meiose	  2.	  Adapted	  and	  modified	  from	  
Sasaki	  et	  al.	  2008	  [37]	  
 
 
1.3.1 Epigenetic	  regulation	  of	  genes	  critical	  to	  mammalian	  spermatogenesis	  
Spermatogenesis, the differentiation of male primordial germ cell to  mature 
spermatozoa, requires specific and comprehensive chromatin and epigenetic 
remodeling [38]. The timing of establishment and removal of methylation marks is 
critical for completing normal spermatogensis, [39] and factors that control histone 
methylation are substantial. In this context the lysine specific histone methyl 
transferases (HMTases) are important players such as the HMTases SUV39H1 and 
SUV39H2 [40]. SUV39H1 and SUV39H2 carries out trimethylation of H3K9 at 
pericentric heterochromatic regions [14]. Methylation of H3K9 results in a high-
affinity binding site for heterochromatin protein 1 (HP1) proteins [41]. Suv39h2 is 
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mainly expressed in testis [42]. In Suv39h2 deficient mice, pachytene spermatocytes 
undergo apoptosis due to incomplete pairing and synapsis. This indicates an essential 
role in the mouse germ cell lineage [40]. Another important HMTase G9a, which is 
claimed to be the major mammalian H3K9 mono- and dimethyltransferase [43] has 
also been proven to be important in male meiosis. Loss of G9a affected spermatocytes 
which failed to develop past the pachytene stage and thus G9a knockout mice were 
sterile [44]. MEISETZ (also known as PRDM1) is a histone methyltransferase that 
mediates H3K4 trimethylation and is arrogated to be necessary for proper meiotic 
prophase progression [45]. Loss of Meisetz leads to deficient pairing of homologous 
chromososmes, meiotic arrest and sterility [45].  
Histone methylation can be reversed by histone demethylases. KDM1 (also known as 
Aof2 or LSD1) is a histone demethylase that demethylates mono and dimethylated 
H3K4 and function in complex with histone deacetylases HDAC1/2, REST 
corepressor 1 (RCOR1) and PHD finger protein 21A (PHF21A) to repress 
transcription [46]. A tightly regulated distribution of KDM1 is presented during 
spermatogenesis [46]. KDM1b a histone H3 lysine 4 demethylase related to KDM1, is 
important for establishing the DNA methylation imprints during oogenesis [47].  
JHDM2A (JmjC-domain-containing histone demethylase 2A) is necessary for 
spermatogenesis, it is expressed during and after meiosis from the late pachytene 
stage until the elongated spermatid stage, with its highest level in round spermatids 
[48]. JHDM2A helps to regulate the expression of the spermatid-specific proteins 
transition nuclear protein 1 (TNP1) and protamine 1 (PRM1) by demethylating mono- 
and di- methylated H3K9 in the promoter regions of these proteins [48]. In a study by 
Okada et al. [48] it was found that mice deficient for Jhdm2a possess post-meiotic 
chromatin condensation defects.  
 
1.3.2 Post-­‐meiotic	  remodeling	  
Elongating spermatides undergo a process called the histone-to-protamine transition 
that prepare these cells for fertilization [49]. In this process histones are replaced with 
transition nuclear proteins (TNP1 and TNP2) followed by the replacement of these 
proteins with protamines (PRM1 and PRM2) [48] resulting in a denser DNA 
packaging in sperm. The nuclear transition proteins are thought to prepare the 
chromatin for association with protamines by affecting DNA condensation [48]. 
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Protamines are only found in spermatids [50], they are small and basic proteins and 
more than 50% of their residues are arginine resulting in high DNA binding affinity 
[49]. Not all histones are replaced by protamines in mature (human) sperm. Rare 
retained nucleosomes with either canonical histones or histone variants exist [51]. In a 
study where nucleosomes retained in mature spermatozoa were mapped, histone 
retention was found at loci important for embryo development, and promoters of both 
micro RNA and imprinted genes [51, 52]. 
 
1.3.3 Histone	  variants	  involved	  in	  spermatogenesis	  
During spermatogenesis histone variants are incorporated into nucleosomes. 
Additionally, the degree of chromatin folding is influenced by the linker histone H1, 
and there are three testis specific H1 variants identified in mammals H1t, H1t2 and 
HILS. H1t displace the somatic H1A and H1B during meiotic prophase and thus 
initiates the restructuring of sperm chromatin [53]. H1t2 appears to play a role in 
directing chromatin condensation [54]. HILS1 (histone H1-like protein in spermatids) 
is confined to elongating spermatids. It is suggested that HILS1 is linked to chromatin 
condensation because of the equal nuclear distribution of HILS1, transition protein 2 
and protamine 1 [55]. 
The histone variant H2AX influence chiasmata formation in meiosis because of its 
function at double-strand breakage sites [56]. H2AX also influence meiotic sex 
chromosome inactivation (MSCI). MSCI is a process where the X and Y 
chromosomes form an XY (or sex) body and become transcriptionally silent in the 
pachytene stage of meiosis [57]. Phosphorylated H2AX (γ-H2AX) localizes to the 
XY body independently of DSBs occurring [18]. H2AX phosphorylation is dependent 
on the DNA repair protein ataxia telangiectasia and Rad3 related (ATR) [58] and 
ATR is dependent on BRCA1 for its recruitment to the XY-body [58]. Thus, H2AX 
phosphorylation, ATR and BRCA1 act together to initiate MSCI [14].  
TH2B (testis-specific histone H2B) is a testis specific variant of the somatic H2B and 
has an important role in the remodeling of chromatin structures during 
spermatogenesis [59]. TH2B has a different phosphorylation pattern than H2B 
because of the addition of three potential phosphorylation sites and repositioning of 
two others in the N-terminal tail of TH2B [60]. The unequal distribution of TH2B in 
the nucleus suggest regulation of specific chromatin domains [60]. Furthermore, 
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TH2B was found in rare retained nucleosomes in human sperm [51]. In a study by 
Hammoud et al. 2009 [51] where the localization of unmodified histones retained in 
sperm was examined, it was found that relative high levels of TH2B were present at 
gene promoters in loci important for sperm biology, capacitation and fertilization, but 
not at developmental loci [51].  
 
1.4 Maintenance	  of	  pluripotency	  
Spermatogonial stem cells maintain a sufficient population of spermatogonia by 
regulated proliferation and differentiation but they also need to ensure a generation of 
self-renewing spermatogonia i.e. some of the spermatogonia need to maintain their 
stem cell potential. This ability to either self renew or differentiate into specialized 
cell types is a key feature spermatogonia have in common with other types of stem 
cells such as hematopoietic stem cells and embryonic stem cells. Embryonic stem 
cells are the most thoroughly studied cell type when it comes to the involvement of 
chromatin and epigenetic factors in the regulation of stem cell potential and 
differentiation. 
In order to maintain a pluripotent state of embryonic stem cells (ES cells), 
pluripotency genes need to be expressed while lineage genes need to be silenced. At 
the same time it is important that lineage genes are rapidly induced upon 
differentiation. Histone modifications play an important role in this regulation. Oct4 
(also known as Pouf1) and Nanog are transcription factors that need to be expressed 
in ES cells and the early embryo to achieve pluripotency [13]. Embryonic stem cells 
(ES cells) are characterized by a specific epigenetic profile [61] where lineage 
specific genes are kept in a state where they are inactive but have the potential for 
activation upon differentiation. This is achieved through the bivalent marking with 
H3K4me3, a mark of active genes, and H3K27me3, a mark of inactive genes at genes 
encoding transcription factors that are important in embryonic development and 
lineage specification [61, 62]. Genes with bivalent marks (Fig. 4) show low-level 
transcription or are silenced in ES cells, and are believed to be poised for 
transcriptional activation upon differentiation. Upon differentiation bivalent ES cell 
domains are for the most part resolved into containing either H3K4me3 or 
H3K27me3 [63] and depending on the particular role of the gene and the 
developmental direction they become either activated or repressed [61]. Worth to 
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mention is that one-third of all genes have neither modifications which suggest the 
presence of other epigenetic markers function to maintain a pluripotent genome [64, 
65]. The role of bivalent marks in the haploid life cycle, i.e. spermatogenesis, has yet 
to be explored/established. 
 
Figure	  4:	  Bivalent	  chromatin	  domains	  mark	  the	  promoters	  of	  developmentally	  important	  genes	  in	  pluripotent	  ES	  cells.	  PRC2	  and	  TrxG	  proteins	  catalyze	  the	  tri-­‐methylation	  of	  histone	  H3	  on	  lysine	  27	  and	  4,	  respectively.	  Genes	  with	  bivalent	  marks	  show	  low-­‐level	  transcription	  or	  are	  silenced,	  and	  are	  believed	  to	  be	  poised	  for	  transcriptionally	  activation	  upon	  differentiation.	  Upon	  differentiation,	  the	  bivalent	  histone	  marks	  can	  be	  resolved	  to	  monovalent	  modifications	  in	  which	  the	  gene	  is	  “ON”	  or	  “OFF”.	  Bivalent	  domains	  can	  also	  be	  maintained	  or	  newly	  established	  in	  lineage-­‐committed	  cells.	  From	  http://www.stembook.org/node/585 
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1.5 Analysis	  of	  histone	  modifications	  by	  chromatin	  
immunoprecipitation	  (ChIP)	  
Chromatin immunoprecipitation is an analytical method for investigating nuclear 
proteins-DNA interactions inside the cell [66, 67] and it involves 
immunoprecipitation of protein/DNA complexes. The concept of ChIP is outlined in 
figure 5. In brief, DNA-binding proteins are reversibly cross-linked to DNA with 
formaldehyde which can cross-link components within a distance of 2 Å [68]. To 
release the chromatin from the cell nucleus, the cross-linked cells are lysed. Next, the 
chromatin is sheared by sonication to generate chromatin fragments of about 200-
1000 bp, with e.g. an average of 500 bp. The lysate is cleared by sedimentation and 
the protein of interest is immunoprecipitated using specific antibodies recognizing, for 
instance as in this study, histone modifications or histone variants. To remove non-
specific bound chromatin the immunoprecipitated complexes are washed under 
stringent conditions. The precipitated chromatin is eluted, cross-links are reversed, 
proteins are digested and the precipitated ChIP-enriched DNA is purified [66]. DNA 
sequences associated with the precipitated protein can be identified by end-point 
polymerase reaction (PCR), quantitative (q) PCR, labeling and hybridization to DNA 
microarrays or direct high-throughput sequencing (ChIP-seq) [66]. 
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Figure	  5:	  The	  chromatin	  immunoprecipitation	  (ChIP)	  assay.	  DNA	  sequences	  associated	  with	  the	  precipitated	  protein	  can	  be	  identified	  by	  end-­‐point	  PCR	  and	  elechtrophorese,	  qPCR,	  labeling	  and	  hybridization	  to	  DNA	  microarrays	  or	  sequencing.	  From	  Collas	  and	  
Dahl	  2008	  [69].	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2 MATERIALS	  	  
 
2.1 Chemicals	  	  
Table	  1:	  Chemicals	  used	  in	  this	  study	  
Name (Company, Catalog number) 
0,1 % SDS (Sigma-Aldrich, L4509) 
0,1 %sodium deoxycholate (Sigma-Aldrich, D5760) 
1% TX-100 ( Sigma-Aldrich, T8787) 
250 mM EGTA  (Sigma-Aldrich,  T3253) 
36.5% Formaldehyde (Sigma-Aldrich, F8775) 
5 M NaCl (Sigma-Aldrich, S5150) 
6x loading buffer (Fermentas, R0611) 
70% (vol/vol) Ethanol 
96% (vol/vol) Ethanol 
Acrylamide carrier (Sigma-Aldrich, A9099) 
Cell Adherence Solution (Crystalgen, 301-025-015)   
Chloroform:Isoamylalcohol, 24:1 (Sigma-Aldrich  C0549-1PT) 
Collagenase type IV (Gibco, 17104-019) 
DAPI (4',6-diamidino-2-phenylindole, dihydrochloride) (Invitrogen, D1306) 
Deoxyribonuclease I from bovine pancreas, DNAse (Sigma Aldrich, DNEP) 
DMEM/F12 (Invitrogen, 11320-074) 
Dynabeads Protein A beads (Invitrogen, 100-020D) 
EDTA (Sigma-Aldrich, E5134) 
Formaldehyde  (Sigma-Aldrich, F8775) 
GeneRuler DNA ladder mix (Fermentas, SM0331) 
Glycine, Sigma-Aldrich G8790 
Goat serum ( DAKO x0907) 
High Capacity cDNA Reverse Transcription Kit (Applied Biosystems, 4368814) 
Hyaluronidase (Sigma, H6254) 
Lysing Matrix D (Medinor / MP Biomedicals, 6913-050) 
PBS (Sigma-Aldrich,  P4417) 
Penicillin-Streptomycin, Pen Strep (Invitrogen, 15070-063) 
Phenol-chloroform-isoamylalcohol 25:24:1v/v (Invitrogen, 15593-031) 
Phenylmethylsulphonyl fluoride, PMSF (Sigma-Aldrich, P7626) 
Phosphate buffered saline (Sigma, p4417) 
Polyacryl-carrier (Molecuar Research Center, Inc PC 152) 
Power SYBR green master mix (Applied Biosystems, 4368702) 
Protease inhibitor mix (Sigma-Aldrich,  P8340) 
Proteinase K (Sigma-Aldrich,  P2308) 
QubitTM dsDNA HS assay kit (Invitrogen Q32851) 
RNAzol RT reagent (Molecuar Research Center, Inc RN 190) 
Sodium acetate, NaAc (Sigma-Aldrich  C8750) 
Sodium Butyrate, Na-butyrate (Sigma-Aldrich, B5887) 
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SYBR® Safe DNA Gel Stain (Invitrogen, S33102) 
Tris-HCl (Sigma-aldrich, T3253) 
Triton X-100 (Sigma-Aldrich T8787) 
Trypsin from bovine pancreas (Sigma-Aldrich,  T1426-50MG) 
TURBO DNA-free KIT (Applied Biosystems, AM1907) 
Tween 20 (Sigma-Aldrich,  P2287) 
Ultrapure agarose (Invitrogen, 16500100) 
UltraPure™ Phenol:Chloroform:Isoamyl Alcohol, 25:24:1, v/v (Invitrogen, 15593-
031) 	  	  	  	  
	  
2.2 Antibodies	  	  
Table	  2:	  Antibodies	  used	  in	  immunofluorescence	  staining	  
Antibodies	   Company,	  Catalog	  number	  Anti-­‐phospho-­‐Histone,	  H2AX	   MedProbe	  /	  Upstate	  Biotechnology,	  05-­‐636	  Anti-­‐SCP3	  antibody	  	   Abcam	  ,ab15092	  Lectin	  PNA,	  Alexa	  Fluor	  594	  conjugated	  	   Invitrogen,	  L-­‐32459	  Alexa	  Fluor	  488	  Goat	  Anti-­‐Mouse	  IgG	   Invitrogen,	  A-­‐11029	  Alexa	  Fluor	  594	  Donkey	  Anti-­‐Rabbit	  IgG	   Invitrogen,	  A-­‐21207	  
 
	  
	  
Table	  3:	  Antibodies	  used	  for	  Chromatin	  immunoprecipitation	  
Antibodies	   Company,	  Catalog	  number	  TH2B	   Upstate,Millipore,	  07-­‐680	  H3K4me3	   Diagenode,	  pAb	  003-­‐050	  H3K9me2	   Diagenode,	  mAb-­‐154-­‐050	  	  H3K9me2	   Diagenode,	  pAb-­‐060-­‐050	  H3K27me3	   Diagenode,	  mAb-­‐181-­‐050	  	  H3K27me3	  	   Diagenode,	  pAb-­‐069-­‐050	  H3K27me3	  	   Millipore,	  CS200603	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2.3 Buffers	  
 
Table	  4:	  Buffers	  used	  in	  this	  study	  
Name	   Contents	  
	  ChiP	  complete-­‐elution	  buffer	   20	  mM	  Tris-­‐HCL,	  pH7.5,	  5mM	  EDTA,	  	  
	  	  
50	  mM	  NaCl,	  20mM	  Na-­‐butyrate,	  1%	  (wt/vol)	  SDS,	  50ug	  ml-­‐1proteinase	  K	  
	  ChIP-­‐elution	  buffer	   20	  mM	  Tris-­‐HCL,	  pH7.5,	  5mM	  EDTA,	  
	  	   50	  mM	  NaCl,	  20mM	  Na-­‐butyrate	  
	  Lysis	  buffer	   50	  mM	  Tris–HCl,	  pH	  8,	  10	  mM	  EDTA,	  	  
	  	   1%	  (wt/vol)	  SDS,	  protease	  inhibitor	  cocktail	  
	  	   (1:100	  dilution	  from	  stock),	  1	  mM	  PMSF	  
	  RIPA	  buffer	   10	  mM	  Tris–HCl,	  pH	  7.5,	  140	  mM	  NaCl,	  
	  RIPA	  ChIP	  buffer	  
1	  mM	  EDTA,	  0,5mM	  EGTA,	  1%	  (vol/vol)Triton	  X-­‐100,	  0.1%	  (wt/vol)	  SDS,	  0.1%	  wt/vol)	  sodium-­‐deoxycholate,)	  10	  mM	  Tris–HCl,	  pH	  7.5,	  140	  mM	  NaCl	  ,	  
	  TE-­‐buffer	  
1	  mM	  EDTA,	  0,5mM	  EGTA,	  1%	  (vol/vol)Triton	  X-­‐100,	  .1%	  (wt/vol)	  SDS,	  0.1%	  wt/vol)Sodium-­‐deoxycholate,	  protease	  inhibitor	  mix(1:100	  dilution	  from	  stock)	  10mM	  Tris-­‐HCL,	  pH	  8,0,	  1mM	  EDTA	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3 Methods	  	  	  
3.1 Cell	  Culture	  and	  Germ	  Cell	  isolation	  
In this study undifferentiated human teratocarcinoma cells NCCIT (CRL-2073) 
obtained from American Type Culture Collection (ATTC) and pachytene 
spermatocytes and round spermatids cells isolated from C57/BL6 mice were used.  
 
 
3.1.1 Cell	  culture	  of	  NCCIT	  cells	  
Cell culture work was performed in laminar air flow hoods (LAF-hood) using sterile 
techniques. The NCCIT cells were cultured in RPMI 1640 medium and grown in 
sterile Nuclon screw cap flasks, T-75 (cm of surface area) and incubated at 37 °C with 
the ambient air containing 5% v/v CO2. Maintenance of the cells consisted of 
removing the confluent cultures (densely grown cells) from the flask and passaging 
into another flask at a lower density. To perform this subculturing the medium was 
removed from the cells attached to the bottom of the flask. Fresh medium was added, 
and the cells dispersed by agitation (by hitting the flask against the palm of one hand). 
Finally, the cells were observed under a microscope. The cells were subcultured twice 
a week. 
 
 
3.1.2 Separation	  of	  germ	  cells	  	  
Pachytene spermatocytes (PCS) and round spermatids (RS) were isolated from 
sexually mature C57/BL6 wild type mice testes using the STA-PUT technique. Cells 
that differ in size, shape and volume have different sedimentation velocity. The STA-
PUT technique utilizes the differential sedimentation velocity at unit gravity to 
separate cells [70, 71]. First a suspension of free germ cells was isolated from the 
testes through washes and enzymatic digestions and then germ cells was separated by 
the STA-PUT apparatus. The separation of germ cells was	  carried out as described by 
Ravindranath et al. 1999 [70] with modifications. 
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Preparation of cell suspension  
 
Procedure: 
1) Under sterile conditions, testes from six C57/BL6 wild type mice were 
removed from the abdominal cavity and put in Dulbecco's Modified Eagle 
Medium/F12 (DMEM/F12) supplemented with antibiotics (100x penicillin 
and streptomycin) 
2) Testes were then placed on a petri dish in a small quantity of DMEM/F12. 
3) To excise and decapsulate the testes, an incision was made in the tunica 
albuginea and the contents were pulled out using tweezers.  
4) The detunicated testes were transferred to a 50 ml tube containing ice cold 
DMEM/F12, allowed to sediment, and washed 3 times in DMEM/F12 by 
pouring 15 ml of DMEM/F12 into the tube, mixing gently, letting the testes 
sediment and removing the DMEM/F12 by a glass-pipette.  
5) After the last wash most of the media was removed, and the detunicated testes 
were poured back into the petri dish and minced into small pieces with a pair 
of scissors. This was done for about five min until a homogeneous medium 
was obtained.  
6) The minced tissue was pipetted back into a 50 ml tube. To be sure of getting 
all of the minced tissue, the petri dish was rinsed with a small volume of 
DMEM. 
7) The minced tissue containing connective tissue, somatic cells and 
seminiferous tubules were washed twice in DMEM/F12 by pouring 15 ml of 
DMEM/F12 into the tube, mixing gently, letting the cells sediment for 5 min 
and removing the DMEM/F12 by a glass-pipette leaving 5 ml in the tube. 
After the last wash most of the DMEM/F12 was removed. 
8) To break down connective tissue and somatic cells, an enzyme mix consisting 
of 10 ml DMEM/F12, 1 mg/ml collagenase type IV and 1 µg /ml DNAse  
were added, mixed and incubated for 8 min at 34 °C on rotation. 
9) After incubation, a glass-pipette was used to help release tubules by pipetting 
up and down several times. A drop of the suspension was placed on a 
microscope slide and checked under a phase contrast microscope. It was 
expected to see long tubules surrounded by interstitial cells. Before removing 
the enzyme-mix, the tubules were allowed to sediment for 5 min 
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10) To remove interstitial cells, tubules were washed 5 times by pouring 15 ml of 
DMEM/F12 into the tube, mixing gently, letting the testes sediment for 5 min, 
and then remove the DMEM/F12 by a glass-pipette. About 2-3 ml of the 
media was allowed to remain between every wash. After the last wash most of 
the media was removed. 
11) In order to break down the tubules and release germ cells, an enzyme mix 
consisting of 10 ml DMEM/F12 with 1 mg/ml collagenase type IV, 1,5 mg/ml 
hyaluronidase, 1mg/ml trypsin and 20 ul DNAse (1µg/ml) were added, mixed 
and incubated for 15 min at 34 °C on rotation. After the incubation, a glass-
pipette was used to break apart the tubules by pipetting up and down several 
times. The cell suspension was then checked under a microscope and it was 
expected to see only free germ cells and no tubules. If tubules were still 
present, the cell suspension was incubated for another 2-3 min at 34 °C on 
rotation and repeated pipetting after that. 
12) The cell suspension was then poured into a fresh 50 ml tube, resuspended in 
10 ml DMEM/F12 with 0,5% BSA and centrifuged 300g for 10 min at 10°C. 
13) After centrifugation, the supernatant was discarded and the cell pellet was 
resuspended gradually by 25 ml of DMEM/F12 with 0.5% BSA and 20 µl 
DNAse. The cells were counted in a Countess® Automated Cell Counter 
(Invitrogen). Expected yield were 1-4x106 cells per ml. The cell suspension 
was then filtered through two cell strainers (70 µm nylon mesh) to remove cell 
aggregates and finally the cells were ready for the STA-PUT apparatus. 
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3.1.3 STA-­‐PUT	  apparatus	  
The STA-PUT apparatus was used to separate germ cells by sedimentation velocity at 
unit gravity at 4 oC by a 2-4% BSA gradient in DMEM/F12. The STA-PUT apparatus 
is illustrated in figure 6. 
 
 
Figure	   6:	   The	   STA-­‐PUT	   apparatus	   consist	   of	   two	   gradient	   chambers,	   a	   cell	   buffer	  chamber,	   two	  magnetic	   stirrers,	   two	   teflon	  spin	  bars,	  a	   sedimentation	  chamber	  with	  a	  STA-­‐PUT	  buffle	  and	  a	  3-­‐way	  micro	  metering	  valve.	  Silicone	  tubes	  connect	   the	  gradient	  chambers,	  cell	  buffer	  chamber	  and	  the	  sedimentation	  chamber	  to	  each	  other.	  The	  figure	  is	  modified	  from	  	  http://www.tecniglas.com/images/STA-­‐PUT.2008.Cdn.Information.pdf.	  
 
 
Procedure: 
1) All connecting tubes were saturated with DMEM/F12 and all air bubbles were 
removed. 
2) The valves were closed and the tubing between the gradient chambers 
clamped.  
3) The two gradient chambers were filled with 550 ml DMEM/F12 with 2% BSA 
and 550 ml DMEM/F12 with 4% BSA. 
4) 50 ml of DMEM/F12 with 0.5% BSA was added to the cell loading chamber 
and allowed to enter the sedimentation chamber.  
5) Then the cell suspension was loaded into the cell buffer chamber, the magnetic 
stirrer was set on, and the cell solution was allowed to go into the 
sedimentation chamber. This was supposed to take about 10 min. 
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6) After the cell suspension was loaded into the sedimentation chamber, the 
magnetic stirrer under the 2% BSA solution was set on, clamps were removed 
and the 2-4% BSA gradient was introduced slowly under the cell suspension, 
displacing the cells to form a thin band near the top of the chamber [72]. The 
gradient was made to stabilize against convection and prevent mixing of 
adjacent layers during loading and unloading of the sedimentation chamber 
[72, 73]. 
7) After approximately 30 min, the valves were closed and the cells were allowed 
to sediment for 2.5 hrs. 
8) After sedimentation, 10 ml fractions were collected and centrifuged at 1000 
rpm for 10 min at 10°C. Then the volume of the fractions was reduced to 1 ml. 
9) Fractions containing pachytene spermatocytes (12-18 µm) and round 
spermatids (8-10 µm) were selected by looking at the cell size and 
morphology using a phase contrast microscope and a Countess® Automated 
Cell Counter.  
10)  Fractions containing the same cell type, PCS or RS, were pooled to obtain 
cell populations enriched in PCS or RS, spun down at 1000 rpm for 10 min at 
10°C. Supernatant was discarded and the cells were resuspended in 1 ml of 
PBS. Then cells were counted in a Countess® Automated Cell Counter. 
11) For microscopic analysis of purity, an aliquot of isolated pachytene and round 
spermatids was fixed on SuperFrost Plus slides (VWR) using Cell Adherence 
Solution, and stored in -20°C freezer.  
 
3.1.4 Animal	  handling	  
Mice were kept under controlled photoperiod conditions (light from 07:00–20:00 h) 
and were supplied with commercial feed and tap water ad libitum. Mice were 
anesthetized with isoflurane and killed by cervical dislocation. All experiments and 
procedures involving the use of animals in research were approved by the Section for 
Comparative Medicine at Oslo University Hospital and by the Norwegian Animal 
Research Authority, complied with national laws and institutional regulations and 
followed the guideline by Federation for Laboratory Animal Science Associations 
(FELASA). 	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3.2 Immunofluorescence	  staining	  of	  pachytene	  and	  round	  spermatids.	  
To asses the purity of the pachytene and round spermatids cells, an aliquot of the 
isolated cells were spread on SuperFrost Plus slides (VWR) and stained with 
fluorescent dyes using antibodies against proteins found in the cells. The pachytene 
spermatocytes were stained with the primary unconjugated antibodies anti-phospho-
Histone H2AX and anti-SCP3 antibody, and the secondary antibodies Alexa Fluor 
488 Goat Anti-Mouse IgG, and Alexa Fluor 594 Donkey Anti-Rabbit IgG. Round 
spermatids were stained with Lectin PNA From Arachis hypogaea (peanut), Alexa 
Fluor® 594 Conjugated. In addition both cell types were counterstained with DAPI 
(4',6-diamidino-2-phenylindole, dihydrochloride) that stained the DNA blue.  
 
Procedure: 
1) Slides were washed quickly in phosphate buffered saline (PBS) and fixated in 
4% paraformaldehyde (PFA) in PBS for 10 min at room temperature (R.T) in 
a fume hood. After fixation the slides were washed twice in PBS for 5 min. 
2) To permeabilize the cells, PBS with 0,5 Triton X-100  was added to the slides 
and incubated for 5 min followed by two washes in PBS. 
3) In order to reduce background staining, the slides were incubated in a blocking 
solution (PBS with 0,1% tween, 5% bovine serum albumin (BSA) and 5% 
goat serum), for 30 min at R.T. 
4) After blocking, slides with pachytene spermatocytes were incubated with the 
primary antibodies namely anti-phospho-histone H2AX and anti-SCP3 diluted 
in antibody diluent solution (PBS with 0,1% tween, 0,5% BSA and 0,5% goat 
serum). The two antibodies were mixed in one solution and thus incubated 
simultaneously. The round spermatids were incubated with diluted conjugated 
PNA. The incubation was carried out in an incubation box at 4°C over night. 
5) To remove unbound primary antibody the slides were washed 3x10 min in 
PBS-tween, and then incubated with the secondary antibody diluted in 
antibody diluent solution (1:500 for both antibodies) for 30 min followed by 
three washes in PBS-tween for 10 min.  
6) Cells were counterstained with DAPI (the DAPI stock solution (5mg/ml) was 
diluted 1:5000 in PBS) for 5 min and washed 3x10 min in PBS. 
7) After the last wash, most of the water was removed from the slides and a drop 
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of the mounting medium Mowiol and a coverslip was added. The mounted 
slides were dried for 2 hrs before they were examined under an Axio 
Observer.Z1 microscope. The minimum numbers of cells examined was 
hundred.  
 
 
3.3 Chromatin	  immunoprecipitation	  (ChIP)	  
In this thesis, ChIP was performed with anti-histone antibodies specific for H3K4me3 
on chromatin from NCCIT cells and antibodies specific for TH2B, H3K4me3, 
H3K9me2 and H3K27me3 on chromatin from pachytene spermatocytes and round 
spermatids. In general ChiP was performed as described previously in the protocol A 
rapid micro chromatin immunoprecipitation assay, Dahl at al. 2008 [66] with 
modifications. 
 
3.3.1 ChIP	  on	  NCCIT	  cells	  
Preparation of Antibody-bead complexes: 
In order to immunoprecipitate chromatin, magnetic beads were loaded with antibodies 
specific for H3K4me3.  
 
Procedure: 
1) 100 µl of well-suspended Dynabeads Protein A beads were placed into a 1,5-
ml eppendorf tube, washed twice in 400 µl RIPA buffer, and resuspended in 
90 µl of the same buffer. 
2) 90 µl RIPA buffer was aliquoted into 200 µl PCR tubes, one tube per chip. 10 
µl of beads and 4 µl of the antibody H3K4me3 (cat# pAb-060-050, 
Diagenode) were added to each tube, the ChIP was performed in triplicate. A 
triplicate of negative controls, (No-antibody control) were also prepared by 
adding the same amount of RIPA buffer and beads into each tube, except the 
antibody. 
3) The antibody-bead complexes were incubated on a rotator at 4oC for at least 2 
hrs. 
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Cross-linking of DNA and proteins  
In order to maintain the association of proteins with their target DNA sequence inside 
the NCCIT cells, formaldehyde was used to reversibly cross-link proteins to DNA. 
Glycine was added to quench the formaldehyde and terminate the cross-linking 
reaction. 
 
Procedure 
1) 270 µl 36,5% formaldehyde was added to NCCIT cells solved in 10 ml 
phosphate buffered saline (PBS), mixed by gentle vortexing and incubated for 
8 min at room temp (R.T)  
2) The cross-linking was quenched for 5 min at room temp by adding 1140 µl 
glycine. From now on the samples were kept on ice and cold buffers were 
used except as otherwise stated. 
3) The cross-linked cells were centrifuged at 400g for 10 min at 4°C in a swing-
out rotor. The supernatant was discarded leaving 30 µl of the solution with the 
cell pellet.  
4) The crosslinked cells were washed twice in 10 ml of ice-cold PBS, by adding 
PBS, mixed and centrifuged with the same settings as above. 
5) After the last wash, the cells were resuspended in 1 ml of PBS and the 
cellsuspension was removed to a 1,5 ml eppendorf tube. The eppendorf tube 
was centrifuged as above and the PBS was discarded leaving 20 µl with the 
cell pellet. 
6) The cross linked cell pellet was frozen in liquid nitrogen and stored at -80°C. 
 
 
Lysis of cells and sonication 
To release chromatin from the nucleus, the crosslinked cells were lysed and the cell 
lysate were sonicated by a Labsonic M sonicator (Labsonic M, Ø3 mm probe, 
Sartorius) to generate sheared, soluble chromatin fragments of 400-500 base pair. 
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Procedure: 
1) 175 µl lysis buffer (R.T) was added to the cell pellet (35µl), vortexed 2x5 s, 
left on ice for 5 min and resuspended by vortexing. 
2) The cell lysate was then sonicated on ice for 10x30 s, with 30 s pauses on ice 
between each 30-s session using a Labsonic M pulse sonicator. The pulse 
settings were: cycle 0.5, 30% power. 
3) The sonicated cells were centrifuged at 12,000g for 10 min at 4°C, and 120 µl 
of the supernatant (chromatin) were transferred into a clean 1.5-ml tube. 
 
 
Absorbance measurement and dilution of chromatin 
To determine the concentration of chromatin an absorbance measurement was done at 
260 nm on a Nanodrop ND-1000 Spectrophotometer (NanoDrop Technologies). The 
chromatin was diluted to 2 A260 in RIPA ChIP buffer. 100 µl chromatin with the 
concentration 2 A260 is equivalent to approximately 100 000 NCCIT cells.  
 
 
Immunoprecipitation and washes 
The anti-histone antibody H3K4me3 was used to capture the histone modification 
H3K4me3 and the interacting DNA. In order to remove non-specific bound chromatin 
the immune complexes were washed. 
 
 
Procedure: 
1) Tubes with bead-antibody incubation was briefly spun down in a table top 
centrifuge and placed in a magnetic rack to pellet beads. 
2) The supernatant was discarded and the beads were washed once in 100 µl 
RIPA buffer. The tubes were removed from the magnetic rack to release the 
beads into the buffer. Then the tubes were briefly vortexed, spun down, placed 
in the magnetic rack and the RIPA buffer was discarded. 
3) 100 µl of fragmented 2U chromatin was added to each tube. The tubes were 
removed from the magnet, vortexed and incubated on a rotator at 4°C for 2 
hrs. 
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4) For input samples and chromatin fragmentation assessment, 100 µl and 20 µl 
respectively of fragmented 2U chromatin, were aliquoted into 1,5 ml 
eppendorf tubes and put on ice. The input samples were run in triplicate. 
5) After incubation the tubes were briefly spun down and placed in a magnetic 
rack to pellet beads. Supernatant was removed and 100 µl RIPA buffer was 
added. The tubes were removed from the magnetic rack, mixed by vortexing 
and placed on a rotator for 4 min at 4°C. This washing step was repeated three 
times in RIPA buffer and once with TE-buffer.  
6) To reduce the background noise the samples in TE buffer were transferred into 
new PCR tubes. 
 
 
DNA-elution, cross-linking reversal and Proteinase K treatment of the 
chromatin 
 
Procedure: 
1) From now on the samples were kept in room temperature. The samples were 
placed in a magnetic rack and the TE-buffer was removed. 
2) DNA elution (1% SDS), cross-link reversal and protein digestion (proteinase 
K) were carried out in one step. For this 150 µl ChiP complete-elution buffer 
was added to the chip-samples. The samples were vortexed and incubated on a 
thermomixer for 2,5 hours at 68oC, 1300 rpm.  For the input samples 200 µl of 
ChIP-elution buffer and 2µl proteinase K were added, and 180 µl Milli Q 
(MQ) water and 2µl proteinase K was added to the fragmentation assessment 
sample. These samples were incubated on a heating block for 2,5 hours at 
68°C. 
3) The ChIP samples were placed in a magnetic rack and the supernatant 
containing precipitated chromatin was collected and placed into a clean 1,5 ml 
eppendorf tube. 
4) 150 µl elution buffer was added to the remaining ChIP material and incubated 
on the thermomixer for 10 min at 60°C, 1300 rpm. The supernatant was 
collected as in 3) and pooled with the first supernatant.  
5) All samples were filled up to 500 µl with ChIP-elution buffer for PCI 
extraction. 
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Phenol-chloroform-isoamylalcohol extraction of the precipitated chromatin. 
 
Procedure: 
1) 500 µl Phenol-chloroform-isoamylalcohol (25:24:1v/v) was added to each 
samples, vortexed vigourosly and centrifuged at 15000 g, 5 min at RT to 
separate the phases. 460 µl of the upper phase containing DNA was collected 
and transferred to a clean tube.  
2)  460 µl of chloroform:isoamylalcohol (24:1) was added, vortexed and 
centrifuged as above and 400 µl of the upper phase was transferred to a clean 
tube. 
3) From this step the samples were kept on ice. The DNA was precipitated by 
adding 40 µl NaAc, 10 µl acrylamide carrier  and 1 ml ice-cold 96% (vol/vol) 
ethanol. Then the samples were vortexed thoroughly and incubated over night 
at -80 °C. 
4) The samples were thawed on ice and centrifuged at 20 000g for 10 min at 4°C. 
5) To wash the DNA pellet, the supernatant was discarded and 1 ml of 70% 
(vol/vol) ethanol at -20°C was added, vortexed briefly and centrifuged at 
15 000 g for. This step was repeated once. 
6) After the last wash most of the ethanol was removed from the samples and 
pellets was left to dry at RT and dissolved in 100 µl TE-buffer. 
 
 
3.3.2 µChIP	  on	  NCCIT	  cells	  
In principal the procedure for small-scale ChIP is the same as for large scale ChiP so 
only the differences are pointed out here. Prior to this ChIP experiment, NCCIT cells 
were cultured, harvested, and cross-linked. The cross-linked cells were counted and 
diluted in order to get cell suspensions with 10 000 cells and 1000 cells for small-
scale ChIP. The 10 000 or 1000 NCCIT cells were lysed by addition of 190 µl lysis 
buffer and sonicated for 3x30 or 4x30 seconds respectively. 400 µl RIPA buffer was 
added to the sonicated samples. The samples were mixed by vortexing and 
centrifuged at 12000 g for 10 min at 4°C. 550 µl of the supernatant was recovered 
into a new tube. 600 µl RIPA ChIP buffer was added to the	  remaining pellet, mixed	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by vortexing and centrifuged as above. 550 µl of the supernatant was recovered and 
pooled with the first supernatant. Then 400 µl RIPA-ChIP buffer was added to the 
pooled chromatin to get a total volume of 1500 µl. The pooled diluted chromatin was 
suitable for 6 parallel ChIPs and 3 parallel input references. 150 µl of chromatin was 
used in each sample. 
 
 
3.3.3 Fragmentation	  assessment	  
In order to obtain chromatin fragments of 400-500 bp, which has been proven to be 
suitable for ChIP-assay [66], the sonication conditions were tested. To test sonication 
conditions 8 samples with 100 000 NCCIT cells per sample were sonicated with 
increased time and the fragmentation size were visualized by agarose gel-
electrophorese. Cross-linked and lysed NCCIT was divided into eight eppendorf tubes 
and sonicated for 1x30, 3x30, 6x30, 10x30, 14x30, 20x30 and 30x30 seconds. One 
tube was not sonicated. The DNA was purified using the phenol-chloroform-
isoamylalcohol extraction methods as described and dissolved in 20 µl Milli-Q water 
and treated with RNAse (10mg/ml) on a thermoblock for 30 min at 37°C. To resolve 
DNA	  fragmentation size a 1,5% agarose solution was made by dissolving 1,5 gram of 
ultrapure agarose in 100 ml TBE buffer. Before casting in gel trays, 3 µl SYBR Safe 
DNA gel stain was added to the agarose solution. SYBR safe is a fluorescent dye that 
makes it possible to visualize DNA using a standard UV transilluminator. Samples 
were prepared by the addition of 6x loading dye and DNA. The agarose gel 
electrophoresis was run for 30 min at 150 volts, 400 mA, 100W in TBE running 
buffer. A DNA ladder containing DNA fragments of known sizes was run alongside 
the samples in the gel to provide a reference for DNA size. 
 
 
3.3.4 ChIP	  on	  spermatogenic	  cells.	  
In general, ChIP assays on pachytene spermatocytes (PCS) and round spermatids 
(RS) were performed as for ChIP on NCCIT cells (3.3.2) and as described previously 
in the protocol A rapid micro chromatin immunoprecipitation assay, Dahl et al. 2008 
[66], with some modification.  
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3.3.5 Chromatin	  preparation	  
In brief fresh purified pachytene- and round spermatids cells resuspended in 1 ml 
PBS, were cross-linked with 27 µl formaldehyde and quenched by 114 µl glycine. 
Cross-linked cells were stored at -80°C. Cell lysis was performed by adding 200 µl 
lysis buffer to the cross-linked cells and vortexing as well as incubation for 5 min on 
ice. The chromatin of PCS and RS was sonicated for 18x30 or 24x30 respectively. 
The cell lysate was cleared by centrifugation (12,000g for 10 min at 4°C) and 180 µl 
of the supernatant was recovered. 13 µl of the supernatant was dedicated for 
fragmentation assessment. The DNA concentration was determined by A260 
measurement and the sheared chromatin was either diluted to 0,13U in RIPA ChIP-
buffer with 1% SDS, or diluted 10x in RIPA ChIP-buffer for storage at -80°C.  
 
 
3.3.6 	  Test	  of	  different	  antibodies	  targeting	  the	  same	  epitope	  	  
Chromatin from PCS was tested with three different antibodies specific for 
H3K27me3, monoclonal and polyclonal antibody from Diagenode (cat#: mAb-181-
050 and pAb-069-050) and a polyclonal antibody from Millipore (cat#:CS200603). 
Chromatin from RS was tested for two antibodies specific for H3K9me2, monoclonal 
and polyclonal antibody from Diagenode (cat#: mAb-154-050 and pAb-060-050)  
In principle the procedure was the same as described for ChIP on NCCIT cells (3.3.1) 
so only the differences were pointed out. The chromatin preparation was carried out 
as above (3.3.5 Chromatin preparation). 120 µl of 0,13 U chromatin was used in each 
sample. The ChIP material was washed three times by 4-min incubations in 100 µl 
RIPA-buffer with 490 mM NaCl and 0,24% SDS. The ChIP samples were run in 
triplicates and duplicates for PCS and RS respectively. 
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3.3.7 Optimization	  of	  washing	  conditions	  for	  ChIP	  
0,13U chromatin from PCS and RS was used in ChIP experiments for test of 
stringency in the washing step. The procedure was the same as above (3.3.6 Test of 
different antibodies targeting the same epitope) except that the ChIP material was 
washed three times by 4-min incubations in either 100 µl RIPA-buffer with 140 mM 
NaCl and 0,1% SDS or 100 µl RIPA-buffer with 490 mM NaCl and 0,24% SDS. 
 
 
3.3.8 Preparation	  of	  ChIP	  DNA	  from	  spermatogenic	  cells	  for	  ChIP-­‐Seq	  	  
5 tubes with cross-linked PCS and 5 tubes with cross-linked RS from five 
independent spermatogenic cell purifications stored at -80 °C were used for ChIP to 
ChIP-seq. For the antibodies H3K4me3 (cat# pAb 003-050, Diagenode), H3k9me2 
(cat# pAb 060-050 Diagenode) and H3K27me3 (cat# CS200603, Millipore), 6 µl was 
coupled to 30 µl Dynabeads Protein A in each ChIP sample, except TH2B (cat# 07-
680, Upstate,Millipore) were 10 µl antibody was used. The cell lysis was performed 
by adding lysis buffer to each tube to a total volume of 200 µl and vortex as well as 
incubation for 5 min on ice. The chromatin of both cell types was sheared by 30 
cycles sonication for 30 sec (Labsonic M, Ø 3 mm probe, cycle 0,5, 30% power, 
Sartorius). The cell lysate was cleared by centrifugation (11 700 g, 4°C for 10 min). 
About 150 µl of the supernatant from each tube was recovered and pooled into one 
tube for each cell type. 20 µl of the supernatant was dedicated for fragmentation 
assessment. The DNA concentration was determined by A260 measurement and the 
sheared chromatin was diluted to 0,2 A260. Chromatin for ChIP with the antibodies 
H3K4me3, H3K27me3, and NoAb was diluted in RIPA buffer with 1% SDS. 
Chromatin for ChIP with the antibodies H3K9me2 and TH2B and the input samples 
were diluted in RIPA-buffer with 0,1%SDS. The diluted chromatin was applied to the 
respective primary antibody-bead complexes. 1,5 ml chromatin was transferred into 
each ChIP sample, except the input samples where 300 µl chromatin was added. The 
ChIP material was washed in RIPA with 0,24% SDS, except the ChIP with 
H3K9me2. DNA from precipitated chromatin and input samples were extracted by 
ethanol precipitation and dissolved in 15 µl EB-buffer. The EB-buffer was diluted 4x 
in MQ water.  
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3.4 Quantitative	  Real-­‐time	  PCR	  (q-­‐rtPCR)	  
Quantitative Real-time PCR (q-rtPCR) was used to quantify immunoprecipitated 
DNA from NCCIT cells, PCS cells and RS cells. It was also used to quantify c-DNA 
in gene expression analysis of PCS and RS. The quantitative PCR reactions were 
carried out on a Step One Plus Real-Time PCR system (Applied Biosystems) with 
Power SYBR green master mix and gene specific primers for selected target genes. 
The Power SYBR® Green PCR Master Mix contains SYBR® Green I Dye, 
AmpliTaq Gold® DNA Polymerase, UP, dNTPs, Passive reference and Optimized 
buffer components [74]. 
In real-time PCR, measurements are made in the exponential phase in contrast to 
traditionally PCR were results are collected after the reaction is completed (Fig. 7a). 
To monitor the accumulation of PCR products, the fluorescent reporter molecule 
SYBR® Green I Dye was used. The SYBR® Green I Dye binds to every double 
stranded DNA in the PCR reaction and fluorescence intensity is measured by the 
instrument. The increase in fluorescence intensity is proportional to the quantity of 
double stranded PCR product produced [75]. Two values are calculated by the 
instrument in the exponentially phase, the Threshold line and the Cycle Threshold. 
The Threshold line is the level of detection when the PCR reaction reaches a 
fluorescent intensity above background. The Cycle Threshold (Ct) is the PCR cycle 
when the sample reaches the threshold line (Fig. 7b). The amount of template DNA in 
an unknown reaction can be precisely determined by comparing the Ct value from the 
sample with unknown concentration with a dilution series of standard containing a 
range of known quantities (Fig. 7c) [76].  
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Figure	   7:	   a)	   Area	   of	   detection	   for	   real-­‐time	   PCR	   and	   endpoint	   PCR.	   b)	   The	   Cycle	  Threshold	  or	  Ct	  is	  the	  PCR	  cycle	  when	  the	  sample	  reaches	  a	  fluorescent	  intensity	  above	  background.	  c)	  Standard	  curve	  made	  of	  a	  dilution	  series	  of	  standards	  containing	  known	  quantities.	   d)	   Amplification	   plot	   of	   5	   samples.	   Figure	   a)	   and	   b)	   taken	   from	  
http://www.invitrogen.no	  [76].	  
 
 
3.4.1 q-­‐rtPCR	  on	  NCCIT	  cells	  
The quantification of chromatin immunoprecipitated DNA from NCCIT cells were 
performed on the Step One Plus Real-Time PCR system, with Power SYBR green 
master mix and gene specific primers for the target sequence human Oct4pp: forward 
5’AGT CTG GGC AAC AAA GTG AGA 3’ and reverse  5’AGA AAC TGA GGA 
GAA GGA TG 3’. 
The concentration of DNA was determined by comparison to a standard curve made 
from a 4x dilutions series of DNA from NCCIT cells with a starting concentration of 
20ng/µl. Seven standards were made. A non-template control was included to see 
primer dimers and contamination of the reaction. All samples were run in duplicates 
and with one technical parallel (2 runs per samples). To highlight the precipitation	  
! !
a	   b	  
c	   d	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efficiency and the extent of unspecific precipitation [66] the data was expressed as 
percent precipitated DNA relative to input.	  	  
 
Procedure:  
1) A mastermix (Table 5) was prepared on ice in a 1,5 ml eppendorf tube for all 
samples to be quantified.  
2) 16 µl of the mastermix and 4 µl of each samples and the standards were 
displaced in each well in the MicroAmpTM Fast Optical 96-Well Reaction 
Plate. 4 µl of MQ water was added to the well with the non-template control. 
3) The reaction plate was mixed gently and centrifuged briefly and then loaded 
into Step One Plus Real-Time machine. PCR condition were 95°C for 5 min 
and 50 cycles of 95°C for 15 sec and 60°C for 1 min. 
 
 
Table	  5:	  q-­‐rtPCR	  mastermix	  
Component	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Volume	  (μl)	  	  	   Per	  sample	   Reaction	  mix	  	  	  	  	  	  	  	  	  	  	  	  X	  samples	  Power	  SYBR®	  Green	  PCR	  Master	  Mix	  	   10	   X*10	  Forward	  primer	  (20pmol/μl)	   0,2	   X*0,2	  Reverse	  primer	  (20pmol/μl)	   0,2	   X*0,2	  H2O	   5,6	   X*5,6	  Total	  	   16	   X*16	  
 
 
 
3.4.2 q-­‐rtPCR	  on	  PCS	  and	  RS	  cells	  
q-rtPCR on pachytene spermatocytes and round spermatids were carried out with the 
same conditions as for q-rtPCR on NCCIT cells (3.4.1). Primers for eight selected 
target genes were used (Table 6) and a mastermix for each target gene was made.  
To quantify the precipitated DNA amount, fragmented DNA from germ cells from 
testes from C57/BL6 mice was used to make a standard curve. Germ cells were 
collected from one round of STA-PUT. Cells were cross-linked, sonicated 9x30 sec 
and DNA was purified using the phenol-chloroform-isoamylalcohol extraction 
method as described. The DNA concentration was measured on a Nanodrop ND-1000 
	   33	  
Spectrophotometer (NanoDrop Technologies). It was made a 4x dilution series of 
DNA, with a starting concentration of 20 ng/µl. The DNA was diluted seven times. 
 
Table	  6: Primers	  used	  in	  q-­‐rtPCR 
Gene	  name	   Forward	  primer	   Reverse	  primer	  
Prm1	   5’	  gcc	  ttg	  ggt	  tat	  cta	  tca	  3’	  	   5’	  tgt	  tca	  gtt	  agt	  cac	  tca	  3’	  	  
Suv39h2	   5’	  aac	  aga	  cag	  cac	  ctc	  tcc	  3’	  	   5’	  ttc	  act	  cca	  cac	  cac	  cag	  3’	  	  
Hdac1	   5’	  aag	  cct	  cgg	  cgt	  att	  ctc	  3’	  	   5’	  gcg	  tgt	  gca	  aag	  atc	  aga	  g3’	  	  
Meisetz	   5’	  gag	  cag	  acc	  taa	  gca	  ctt	  3’	  	   5’	  gtg	  tta	  cct	  gac	  ctg	  tgt	  3’	  	  
HoxD4	   5’	  ctg	  ggt	  agg	  acc	  cga	  ggt	  tg	  3’	  	   5’	  ggc	  tgt	  aca	  att	  tca	  cca	  ggc	  3’	  	  
Jhdm2a	   5’	  ctt	  atc	  tgt	  gag	  cct	  gtg	  3’	  	   5’	  ttc	  ttc	  cat	  ttg	  ttg	  cct	  3’	  	  
Nanog	   5’	  cta	  tcg	  cct	  tga	  gcc	  gtt	  g	  3’	  	   5’	  aac	  tca	  gtg	  tct	  aga	  agg	  aaa	  gat	  ca	  3’	  	  
Oct4	   5’	  ctg	  taa	  gga	  cag	  gcc	  gag	  ag	  3’	  	   5’	  cag	  gag	  gcc	  ttc	  att	  ttc	  aa	  3’	  
 
 
 
3.5 Reverse	  Transcription	  PCR	  	  
In order to quantify gene expression levels in pachytene spermatocytes and round 
spermatids, a Real-Time RT PCR experiment was conducted. Total RNA was 
extracted from snap frozen pellets of PCS and RS, and a reverse transcription PCR 
(RT-PCR) reaction synthesized cDNA from total RNA. The resulting cDNA was used 
as template in q-rtPCR.  
 
 
3.5.1 Isolation	  of	  total	  RNA	  
RNAzol RT reagent was used to extract total RNA from snap frozen pellets of 
pachytene spermatocytes and round spermatids. The isolation was done according to 
the RNAzol protocol for isolation of total RNA with some adjustments [77]. Pellets 
were lysed and homogenized in RNAzol RT. Molecules like DNA, proteins and 
polysaccharides were precipitated from the lysate by adding diethylpyrocarbonate 
treated water (DEPC water), and removed by centrifugation. The RNA containing 
supernatant was precipitated by the addition of Polyacryl-carrier and isopropanol, 
followed by two washes in ethanol and solubilization in DEPC water. 
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Procedure: 
1) Cell pellets of 100 000 – 300 000 cells were lysed and homogenized by adding 1 
ml RNAzol, displacing the suspension to a tube containing Lysing Matrix D and 
then homogenized in a FastPrep instrument.  
2) The homogenized cells were then transferred to a new 2 ml tube, 0,4 ml DEPC 
water was added and mixed for 15 seconds, stored at the bench for 15 min and 
then centrifuged at 12 000 g for 15 min.  
3) One ml of the RNA containing supernatant was displaced to a new tube and RNA 
was precipitated by adding 2 µl Polyacryl-carrier  and 1 ml of isopropanol, left 10 
min on the bench and centrifuged at 12 000 g for 10 min.  
4) The RNA pellet was washed twice by adding 0,5 ml 75% ethanol, mix and 
centrifuged 1 minute at 4000 g. 
5) The supernatant was removed and the RNA pellet was dissolved, without drying, 
in 50 µl DEPC water. 
 
 
3.5.2 DNase	  treatment	  of	  total	  RNA	  
To degrade any genomic DNA remnants from the RNA preparations, a TURBO 
DNA-free KIT was employed according to the manufactures protocol [78]. 
 
 Procedure: 
1) 5µl 10x TURBO DNase Buffer and 1 µl TURBO Dnase were added to 44 µl 
total RNA, mixed gently and incubated at 37oC for 30 min. 
2) After the incubation, 5µl of resuspended DNAse inactivation Reagent was 
added, mixed well and incubated at R.T for 2 min. 
3) The suspension was centrifuged at 10 000 g for 1,5 min and the RNA 
supernatant was transferred to a fresh tube. 
 
 
 
	   35	  
 
3.5.3 Quantification	  of	  RNA	  by	  photometric	  analysis	  
To determine concentrations and purity of RNA, a NanoDrop ND-1000 
Spectrophotometer was used. Measurement at both 260 nm and 280 nm give an 
absorbance ratio A260/280 and this ratio is used to assess the purity of RNA.  For pure 
RNA the acceptable ratio is approximately 2,0. If the ratio is lower than the 
acceptable value, it may indicate presence of contaminants that absorb near 280 nm 
[79]. 
 
 
3.5.4 Reverse	  transcription	  of	  RNA	  to	  cDNA	  
A High Capacity cDNA Reverse Transcription Kit was used in order to synthesize 
single-stranded cDNA from total RNA. During the RT reaction random primers 
hybridizes to RNA and reverse transcriptase synthesizes a single-stranded DNA 
molecule complementary to the RNA. To determine genomic DNA contamination in 
the RNA samples, minus reverse transcriptase (-RT) controls were included. It is 
important that the RNA does not contain any genomic DNA because this may lead to 
false positive results in the q-rtPCR. A –RT control contains all the RT-PCR reagents 
except the reverse transcriptase. The reverse transcription reaction was carried out in 
duplicates, with an –RT control for each cell type. Equal amounts of total RNA (3 ng) 
from each cell type were used, and to avoid experimental variation they were 
processed simultaneously. The RNA concentrations were 3 ng. The High Capacity 
cDNA Reverse Transcription Kit was used according to manufactures protocol [80]. 
 
Procedure:  
1) A 2X RT mastermix was prepared on ice in a 1,5 ml eppendorf tube for all 
total RNA samples to be reversed transcribed, mixed and spun down. A RT 
mastermix for – RT control was prepared in a separate tube (Table 7)  
2) Six 0,2 ml PCR tubes were labelled, 4 for the samples and two for the –RT 
control. 
3) 10 µl of the mastermix and 10 µl of each total RNA samples were displaced to 
the corresponding tube, mixed gently and centrifuged briefly.  
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4) The tubes were then loaded into a thermal cycler with conditions as follow: 
25°C for 10 min, 37°C for 120 min and 85°C for 5 min. 
 
Table	  7:	  2X	  RT	  mastermix	  	  
Component	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Volume	  (μl)	   	  	  	  -­‐RT	  control	  	  	   Per	  sample	   Reaction	  mix	  (x4)	   Reaction	  mix	  (x2)	  10X	  RT	  Buffer	   2	   8	   4	  25X	  dNTP	  Mix	  (100	  mM)	   0,8	   3,2	   1,6	  10X	  RT	  Random	  Primers	   2	   8	   4	  MultiScribe	  Reverse	  Transcriptase	   1	   4	   	  	  	  -­‐	  Nuclease-­‐free	  H2O	   3,2	   12,8	   8,4	  Total	  	   10	   40	   20	  
 
 
 
3.5.5 q-­‐rtPCR	  on	  cDNA	  	  	  
q-rtPCR on cDNA was carried out with the same conditions as for q-rtPCR on NCCIT 
cells (3.4.1). Pre-designed primers (table 8) for seven selected target genes (Jhdm2a, 
Nanog, HoxD4, Suv39h2, Prm1, Meisetz, Hdac1) and two endogenous control genes 
(Gapdh and β-Actin) were used and a mastermix (Table 5) for each gene was made. A 
–RT control for each cell type was also included for each target gene to be amplified. 
The cDNA was quantified by comparison to a standard curve made from cDNA from 
the same stock of mixed cDNA from pachytene spermatocytes and round spermatids. 
It was made a 3x dilution series of the cDNA with a starting concentration of 1,25 
ng/µl. As endogenous controls two housekeeping genes, glyceraldehyde 3-phosphate 
dehydrogenase (Gapdh) and β-Actin were used. The endogenous controls should be 
expressed at similar levels in all samples tested, and was used to normalize 
fluorescence signals for the target that are to be quantified. 
 	  
Table	  8:	  Primers	  used	  in	  q-­‐rtPCR	  on	  cDNA 
Gene	  name	   Forward	  primer	   Reverse	  primer	  
Nanog	   5’	  caa	  gaa	  ctc	  tcc	  tcc	  att	  3’	  	   5’	  tga	  atc	  aga	  cca	  ttg	  cta	  3’	  	  
HoxD4	   5’	  tac	  cct	  tgg	  atg	  aag	  aag	  3’	  	   5’	  tgg	  tca	  gat	  acc	  tgt	  taa	  3’	  	  
Hdac1	   5’	  tgg	  tcg	  caa	  gaa	  ctc	  ttc	  3’	  	   5’	  ttc	  tgg	  ctt	  ctc	  ctc	  ctt	  3’	  	  
Suv39h2	   5’	  atg	  agt	  tca	  cag	  tgg	  atg	  3’	  	   5’	  gcc	  gag	  tat	  caa	  ggt	  tat	  3’	  	  
Prm1	   5’	  agc	  aaa	  agc	  agg	  agc	  aga	  3’	  	   5’	  cat	  cgc	  ctc	  ctc	  cgt	  ctg	  3’	  	  
Meisetz	   5’	  gaa	  gag	  aac	  taa	  gga	  cag	  aa	  3’	  	   5’	  agt	  gcg	  atg	  att	  cca	  ttc	  3’	  	  
Jhdm2A	   5’	  cgc	  cac	  atc	  agg	  ttc	  ata	  3’	  	   5’	  taa	  gcc	  aga	  agc	  agt	  gtt	  3’	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3.6 Qubit	  
In order to determine the concentration of ChiP DNA before whole genome 
sequencing, a Qubit® 2.0 Fluorometer together with QubitTM dsDNA HS assay kit 
was used. The QubitTM dsDNA HS assay kit contains QubitTM dsDNA HS buffer, 
QubitTM dsDNA HS Standard #1, QubitTM dsDNA HS Standard #2 and QubitTM 
dsDNA HS Reagent (which is a fluorerscence-based dye that fluoresce when bound to 
DNA. The fluorescence are detected with a photodiode in the Qubit® 2.0 Fluorometer 
and the measurement was done according to the Qubit® 2.0 Fluorometer, User 
Manual [81].  
 
 
Procedure: 
1) A Qubit working solution was made for all samples and standards to be 
measured by diluting the QubitTM dsDNA HS reagent 1:200 in QubitTM 
dsDNA HS buffer. 
2) 190 µl of QubitTM working solution was loaded into each of the tubes used 
for standards and 10 µl of each QubitTM standard was added to the 
appropriate tube and mixed by vortexing.  
3) 199 µl of QubitTM working solution and 1 µl of samples was loaded into the 
corresponding tubes and vortexed.  
4) All tubes were allowed to incubate at R.T. for 2 min. 
5) Before measuring the samples, a calibration was done by measuring the two 
standards. 
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3.7 Whole-­‐Genome	  Chromatin	  Immunoprecipitation	  Sequencing	  
(ChIP-­‐seq)	  
To globally map the location of the histone modifications H3K4me3, H3K9me2 and 
H3K27me3 in addition to the histone variant TH2B, High-throughput sequencing was 
performed on immunoprecipitated DNA from PCS and RS. The whole-genome ChIP 
sequencing was performed at Bejing Genomics Institute (BGI). For library-
preparation the Illumina sample preparation kit was used and the sequencing was 
carried out using the Illumina/Solexa Genome Analyzer sequencing system. The 
experimental pipeline of ChIP-seq is showed in figure 8. ChIP DNA and Input 
samples were prepared for solexa sequencing by producing a DNA library of adapter 
modified fragments [82]. In brief the adapter modified fragments are made by DNA-
end repair, 3’-dA overhang and ligation of sequencing adaptors. Adapter ligated DNA 
fragments are size fractionated in an agarose-gel and fragments of 200-500 bp are 
isolated via gel-extraction and amplified in a PCR reaction with limited cycles [83].  
On the Illumina Cluster Station adapter-ligated ChIP DNA fragments are amplified on 
a solid flow cell substrate and clusters of clonal ChIP-DNA fragments are made. The 
clusters of clonal ChIP-DNA fragments on the flow cell surface are sequenced by 
Illumina Genome Analyzer. 
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Figure	  8:	  Experimental	  pipeline	  of	  ChIP-­‐seq.	  Cell	  line	  samples	  were	  through	  ChIP	  enrichment.	  ChIP	  DNA	  was	  fragmented	  to	  100-­‐500bp	  by	  sonication.	  DNA-­‐end	  was	  repaired	  to	  overhang	  a	  3’-­‐dA	  and	  adapters	  were	  ligated	  to	  the	  end	  DNA	  fragments.	  DNA	  fragments	  with	  proper	  size	  (	  200-­‐300bp,	  including	  adaptor	  sequence)	  were	  selected	  after	  PCR	  amplification.	  Finally	  qualified	  library	  for	  sequencing	  was	  achieved.	  Figure	  taken	  from	  BGI	  (BGI-­‐	  www.genomics.cn)	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3.7.1 Mapping	  of	  sequenced	  reads	  and	  peak	  calling	  
For mapping (Fig. 9), the mm9 mouse genome was used as the reference genome. The 
July 2007 mouse (Mus musculus) genome data were obtained from the Build 37 
assembly by NCBI and the Mouse Genome Sequencing Consortium. This assembly is 
also known as UCSC mm9. ChIP-Seq reads were mapped to the genome reference by 
SOAP. MACS version 1.4.0 was used with default parameters to identify regions of 
the genome significantly enriched in the histone modifications H3K4me3, H3K9me2, 
H3K27me3 and the histone variant TH2B. 	  	  
	  
Figure	  9:	  Mapping	  of	  sequenced	  reads	  and	  peak	  calling.	  1)	  Colour	  images	  generated	  from	  Solexa	  sequencing	  are	  translated	  into	  nucleotide	  sequences,	  and	  2)	  mapped	  to	  a	  reference	  genome.	  3)	  The	  number	  of	  reads	  associated	  with	  genomic	  regions	  is	  analysed	  and	  regions	  of	  enrichment	  ,	  or	  peaks	  are	  identified.	  Figure	  taken	  from	  Cullum	  et	  al.	  2011	  
[84].	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4 FRAMEWORK	  AND	  OBJECTIVES	  OF	  THE	  STUDY	  
 
Histone and histone variants have been shown to play an essential role in many 
cellular functions including DNA replication, DNA repair, mitosis, meiosis and 
regulation of gene expression. The role of histone modifications and variants in these 
cellular functions can be studied using the ChIP method. Such investigation can 
reveal the exact location of histone proteins and post-translationally modified histones 
in relation to gene regulatory regions or other genomic regions of functional relevance 
to the studied biology. Moreover, comparison of colocalization of various histone 
modifications or variants within and across cell types can shed light on the functional 
role of these histone modifications or variants. 
My work has consisted in acquiring solid skills in several methods, with an emphasis 
on ChIP and STA-PUT and further applying those skills in the optimization of the 
ChIP conditions for PSC and RS in the assessment of three histone modifications and 
one histone variant. The established experimental conditions was first used for a pilot 
study of a panel of selected genes, and further laid the ground for ChIP-seq, resulting 
in genome-wide data which will be further analyzed after the completion of this 
thesis. 
 
The objective of this study was to initiate the investigation of the role of the testis 
specific histone variant of H2B, i.e. TH2B, and the role of the developmentally 
important bivalent chromatin marks H3K27me3 and H3K4me3 in 
spermatogenesis. Several issues were addressed under these specific aims: 
 
1) Assess experimental conditions of the ChIP procedure which could result in 
reduced background and an increased signal to noise ratio. 
2) Identify the most promising commercially available antibodies for 
H3K27me3, H3K4me3, H3K9me2 and TH2B and determine experimentally 
which antibodies that perform best in distinguishing loci with high and low 
levels of the specific histone target. 
3) Achieve isolation of PSC and RS at purity comparable to the best reported in 
the literature. 
4) Achieve isolation of sufficient numbers of PCS and RS to allow for ChIP-seq. 
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5) Investigate the relationship, i.e. correlation in occupancy of TH2B with 
H3K9me2, H3K27me3 and H3K4me3 at the promoters of a selected number 
of genes to shed light on the role of TH2B. 
6) Investigate the presence of bivalency of H3K4me3 and H3K27me3 at the 
same loci at promoter regions of selected genes in PCS and RS. 
7) Achieve ChIP-seq data which can be used for further analysis of the 
relationships listed under point 5) and 6) 
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5 RESULTS	  	  
5.1 Initial	  optimization	  of	  the	  ChIP	  assay	  
Sonication of genomic DNA cross-linked to proteins is a crucial step in all ChIP 
projects. Sonication conditions were initially tested for 8 samples with 100 000 
NCCIT cells per sample with	   increasing	   sonication	   time.	  The	   fragmentation	   size	  was	  visualized	  by	  agarose	  gel-­‐electrophoreses.	  As	  expected,	  increased	  sonication	  time	  resulted	  in	  smaller	  DNA	  fragments	  (Fig.	  10).	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Figure	   10:	   Agarose	   gel	   electrophoresis	   assessment	   of	   chromatin	   after	   increased	  sonication	  regimes.	  M:	  Gene	  ruler	  DNA	  ladder	  mix.	  
 
 
ChIP was initially optimized with chromatin from 100 000 and 10 000 NCCIT cells 
with H3K4me3 antibody. The level of this histone modification at the promoter of 
Oct4 was assessed by q-rtPCR. The q-rtPCR data revealed higher precipitation 
efficiency and increased standard deviation between replicates with 10 000 cells (Fig. 
11). In order to reduce NoAb background of unspecifically bound chromatin, we 
modified the ChIP procedure; the ChIP samples were subjected to vortexing when 
adding	   fresh	   washing	   solution, rather than gentle agitation. This physically rough 
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treatment of ChIP samples lead to comparable background levels despite of a 
reduction in cell numbers from 100 000 to 10 000 cells.  
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Figure	  11:	  ChIP	  on	  NCCIT	  cells.	  ChIP	  was	  performed	  with	  chromatin	  from	  100	  000	  and	  10	  000	  NCCIT	  cells.	  The	  enrichment	  of	  H3K4me3	  on	  the	  promoter	  of	  Oct4	  was	  assessed.	  The	  high	  and	  low	  cell	  number	  ChIP	  experiments	  were	  both	  performed	  in	  triplicate,	  and	  assessed	  by	  duplicate	  q-­‐rtPCR	  for	  each	  replicate.	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5.2 Isolation	  and	  validation	  of	  PCS	  and	  RS	  	  
Cells from two different spermatogenic cell stages, pachytene spermatocytes and 
round spermatids, were isolated from C57/BL6 wild type mice testes using the STA-
PUT technique (Fig. 12). Testes from six mice were used in each round of STA-PUT, 
and the amount of PCS cells and RS cell isolated each round were on average 1,6x106  
and  > 4,0 x106, respectively.  
 
 
Figure	  12:	  Isolation	  of	  PCS	  and	  RS.	  a)	  Testis	  from	  six	  C57/BL6	  mice.	  b)	  Multicolor	  fluorescence	  image	  of	  mouse	  testis,	  cross-­‐section.	  c)	  The	  STA-­‐PUT	  apparatus.	  d)	  Automatic	  fraction	  collector.	  e)	  f)	  Phase	  contrast	  micrographs	  of	  PCS	  and	  RS	  respectively.	  Picture	  b	  taken	  from	  
http://www.invitrogen.com/site/us/en/home/support/Research-­‐Tools/Image-­‐
Gallery/Image-­‐Detail.2187.html.	  Picture	  e	  and	  f	  modified	  from	  Santi	  C	  M	  et	  al.	  J	  Gen	  
Physiol	  1998;112:33-­‐53	  
 
 
To assess the purity of the pachytene spermatocytes and round spermatids, cells were 
stained with fluorescent dyes using antibodies against proteins unique for these cells 
(Fig 13). The pachytene spermatocyte cells were stained with the primary antibodies 
anti-phospho-Histone H2AX and anti-SCP3 (Synaptonemal Complex 3).  
Phosphorylated H2AX (γ-H2AX) localizes to the XY body in the pachytene stage of 
spermatogenesis. The SCYP3 protein is a component of the synaptonemal complex 
formed during prophase 1 of meiosis, between homologous chromosomes. Round 
spermatids were stained with Lectin PNA that is specific for acrosome. In addition 
both cell types were counterstained with DAPI that stained the DNA blue. The stained 
cells were examined under an Axio Observer. Z1 plan 2 microscope and hundred PCS 
or RS cells were examined on each slide made from each round of purification. The 
pachytene spermatocytes were found to have a purity of 83% and the round 
spermatids showed a purity of 82%.  
a	   c	   d	  
b	  
e	  
f	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DAPI                           Lectin PNA              Merge 
Figure	  13:	   Immunofluorescence	   staining	   of	   pachytene	   spermatocytes	   and	   round	  
spermatids.	  Pachytene	  spermatocytes	  were	  stained	  with	  a)	  DAPI,	  b)	  γ-­‐H2AX	   ,	  c)	  SCP3,	  
d)	  merging	  of	  picture	  a,	  b	  and	  c.	  Round	  spermatids	  were	  stained	  with	  e)	  DAPI,	  f)	  Lectin	  PNA	  	  and	  g)	  merging	  of	  picture	  e	  and	  f.	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PCS and RS isolated from five independent spermatogenic cell purifications (STA-
PUT) were used for ChIP to ChIP-seq. The purity of the PCS and RS was on average 
83% and 82%, respectively (Table 9). The average cell size was 11,5 µm for PCS and 
8,5 µm for RS. 
 
 
 
 
Table 9: Purity of PCS and RS. PCS and RS isolated from five independent 
spermatogenic cell purifications (STA-PUT) were used for ChIP to ChIP-seq. a) 
Purity of pachytene spermatocytes. b) Purity of round spermatids 
 a) 
Pachytene	  spermatocytes	   	  	   	  	  
ID Number Size (µm) Purity (%) 
1 1,4x106 12,1  - 
2 1,6x106 11,1 85 
3 1,5x106   11,5 86 
4 1,1x106   11,1 80 
5 2,3x106   11,7 80 
Total/average	   7,9x106   11,5 83 
b)	  
	   	   	  Round	  spermatides	   	  	   	  	  
ID Number Size (µm) Purity (%) 
1 < 1,0x107   8,4 80 
2 < 1,0x107   8,9 87 
3 7,2x106 8,5 83 
4 5,0x106   8,4 81 
5 3,2x106   8,5 78 
Total/average	   < 1,0x107   8,5 82 
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5.3 Optimization	  of	  washing	  conditions	  for	  ChIP	  
120 µl 0,13U chromatin from PCS and RS was used in a ChIP experiment with 
antibodies against H3K4me3, H3K9me2, H3K27me3 and TH2B for test of stringency 
in the washing step. The ChIP material was washed three times by 4-min incubations 
in either 100 µl RIPA-buffer with 140 mM NaCl and 0,1% SDS (from now on called 
RIPA-buffer with 0,1% SDS) or 100 µl RIPA-buffer with 490 mM NaCl and 0,24% 
SDS (from now on called RIPA-buffer with 0,24% SDS). Quantitative PCR (qPCR) 
was performed on loci known to have high and low levels of the histone 
modifications and variant to validate the outcome of increased stringency. ChIP 
samples with antibody against H3K4me3 (Fig. 14a and b) showed a slightly higher 
precipitation efficiency when washed in 0,1% RIPA-buffer. The H3K9me2 samples 
(Fig. 14 d and e) showed a decrease in precipitation efficiency when washed in RIPA-
buffer with 0,24 % SDS. The H3K27me3 antibody (Fig. 14g) was tested directly in 
ChIPs with high stringency RIPA buffer (RIPA buffer with 0,24% SDS) and showed 
an enrichment of almost 150 between the high and low target gene for this histone 
modification (Fig. 14h). The TH2B antibody (Fig. 14i-j) showed a precipitation 
efficiency of 4% on the Nanog promoter and 1,4% on the Jhdm2a promoter with the 
0,1% SDS RIPA-buffer. In washes with RIPA-buffer with 0,24% SDS the 
precipitation efficiency was 2,8% and 0,4% for Nanog and Jhdm2a respectively, thus 
the wash in 0,24% RIPA-buffer gave a higher fold enrichment (Fig. 14k) than the 
wash in 0,1% buffer for TH2B. 	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Figure	  14:	  Optimization	  of	  ChIP	  washing	  conditions.	  Washes	  in	  RIPA-­‐buffer	  with	  140	  mM	  NaCl	  and	  0,1%	  SDS	  (called	  0,1%	  SDS)	  and	  RIPA-­‐buffer	  with	  490	  mM	  NaCl	  and	  0,24%	  SDS	  (called	  0,24%	  SDS)	  was	  tested	  for	  each	  antibody.	  The	  precipitation	  efficiency	  was	  visualized	  in	  q-­‐rtPCR	  for	  selected	  target	  genes	  known	  to	  have	  high	  and	  low	  enrichment	  for	  the	  respective	  antibody.	  Enrichment	  reflects	  the	  ratio	  of	  our	  selected	  genes	  with	  the	  highest	  level	  of	  the	  relevant	  histone	  modification	  over	  that	  of	  our	  genes	  with	  the	  lowest	  level	  of	  the	  same	  modification.	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5.4 Comparison	  of	  different	  antibodies	  targeting	  the	  same	  epitope	  
and	  the	  effect	  on	  ChIP	  efficency	  
Chromatin from PCS was tested with three different antibodies specific for 
H3K27me3, monoclonal and polyclonal antibody from Diagenode (cat# mAb-181-
050 and pAb-069-050) and a polyclonal antibody from Millipore (cat# CS200603). 
Chromatin from RS was tested for two antibodies specific for H3K9me2, monoclonal 
and polyclonal antibody from Diagenode (cat# mAb-154-050 and pAb-060-050)  
120 µl of 0,13 U chromatin was used in each sample. To evaluate the precipitation 
efficiency for the aforementioned antibodies, each ChIP-sample was analyzed with 
primers for loci we know have high and low enrichment for each histone modification 
in real-time PCR. Loci with high and low enrichment of H3K9me2 and H3K27 have 
previously been identified (unpublished data). The monoclonal Ab against H3K9me2 
had a precipitation efficiency of around 2% whereas the polyclonal Ab showed an 
efficiency of around 11% for the Nanog promoter (Fig. 15a). For the Jhdm2a loci, the 
mono- and polyclonal H3K9me2 antibody obtained a precipitation efficiency of 0,2 % 
and 2,1% respectively (Fig. 15b). In relation to the enrichment obtained by these 
antibodies, monoclonal H3K9me2 had a higher fold enrichment compared to the 
polyclonal H3K9me2 (Fig. 15c). In relation to the histone modification H3K27me3 
(Fig. 15d and e), the polyclonal H3K27me3 from Diagenode showed the highest 
precipitation efficiency for both HoxD4 and Jhdm2a loci. The monoclonal antibody 
from Diagenode displayed the lowest efficiency, while the polyclonal Ab from 
Millipore presented highest fold enrichment (Fig. 15f). 
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Figure	  15:	  Comparison	  of	  different	  antibodies	  targeting	  the	  same	  epitope	  and	  the	  
effect	  on	  ChIP	  efficiency.	  The	  ChIP	  experiments	  were	  performed	  in	  either	  duplicate	  or	  triplicate	  for	  all	  antibodies,	  and	  assessed	  by	  duplicate	  q-­‐rtPCR	  for	  each	  replicate.	  	  a),	  b)	  The	  graphs	  shows	  the	  analysis	  of	  monoclonal	  and	  polyclonal	  H3K9me2	  from	  Diagenode	  and	  no-­‐antibody	  (NoAb)	  as	  a	  negative	  control,	  binding	  to	  the	  Nanog	  (a)	  and	  Jhdm2a	  (b)	  promoters.	   c)	   The	   graph	   shows	   the	   ratio	   of	   enrichment	   of	   	   mono-­‐	   and	   poly-­‐clonal	  H3K9me2	  d),	   e)	   The	   graphs	   shows	   the	   analysis	   of	   mono-­‐	   and	   polyclonal	   H3K27me3	  from	  Diagenode,	  polyclonal	  H3K27me3	  from	  Millipore	  and	  NoAb	  binding	  to	  the	  HoxD4	  (d)	  and	  Jhdm2a	  (e)	  promoters.	  f)	  The	  graph	  shows	  the	  ratio	  of	  enrichment	  of	  mono-­‐	  and	  polyclonal	   H3K27me3	   from	   Diagenode	   and	   polyclonal	   H3K27me3	   from	   Millipore	   In	  figure	   a),b),d)	   and	   e)	   data	   are	   expressed	   as	   percent	   precipitation	   relative	   to	   input	  chromatin	   (mean	  values	  ±	  s.d).	   	  Enrichment	  c)	  and	   f)	   reflects	   the	   ratio	  of	  our	  selected	  genes	  with	  the	  highest	  level	  of	  the	  relevant	  histone	  modification	  over	  that	  of	  our	  genes	  with	   the	   lowest	   level	   of	   the	   same	   modification	  mAb	   Dia:	   monoclonal	   antibody	   from	  Diagenode;	  pAb	  Dia:	  polyclonal	  antibody	  from	  Diagenode;	  pAb	  Milli:	  polyclonal	  antibody	  from	  Millipore.	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5.5 Occupancy	  of	  the	  histone	  variant	  TH2B	  and	  the	  histone	  
modifications	  H3K4me3,	  H3K9me2	  and	  H3K27me3	  on	  gene	  
promoters	  	  
0,13U chromatin from PCS and RS was used in ChIP experiments with antibodies 
against H3K4me3, H3K9me2, H3K27me3 and TH2B to assess histone modifications 
profiles at proximal promoters (PP) of the transcription factors genes Nanog, HoxD4 
and Oct4; the histone methyltransferases Suv39h2 and Meisetz; the histone 
demethylase Jhdm2a; the histone deacetylase Hdac1 and the protamine gene Prm1.  
Note that the immunoprecipitation efficiency is antibody dependent. Therefore the 
level of precipitation cannot be directly compared between antibodies. 
The testis specific histone variant TH2B (Fig. 16a) showed relatively high enrichment 
at the Nanog, HoxD4 and Oct4 promoters. The promoters of Suv39h2, Meisetz and 
Prm1 also showed a relatively high enrichment of TH2B, while there were lower 
levels of TH2B on Jhdm2a and Hdac1 promoters.  
The histone modification H3K9me2 (Fig. 16b) correlated well with the TH2B profile 
on all gene promoters tested.  
H3K27me3 (Fig. 16c) showed high levels at the Hoxd4 promoter, with a decline to 
about the half from the pachytene to the round spermatid stage. We found an 
intermediate level of H3K27me3 on Oct4. Prm1 showed a slight enrichment of 
H3K27me3 in PCS while there where hardly any occupancy of this histone 
modification at this site in RS. Suv39h2, Meisetz, Jhdm2a and Hdac1 showed very 
low levels of H3K27me3 for both cell types. In summary the level of H3K27 was 
high at the genes with the highest H3K9me2 and TH2B levels i.e. the Hoxd4 and Oct4 
promoter.  
The level of the histone modification H3K4me3 (Fig. 16d) were high at promoters of 
the methyltransferases Suv39h2 and Meisetz, the demethylase Jhdm2a and the 
deacetylase Hdac1 at both cell stages. The HoxD4, Oct4 and Prm1 locus showed 
lower levels of H3K4me3 compared to the aforementioned gene promoters. With the 
exception of the Suv39h2 promoter, there was an increase in the H3K4me3 level from 
the PCS to the RS stage for the rest of the genes harboring high levels of this mark: 
Meisetz, Jhdm2a and Hdac1  
 
 
 
	   53	  
 
H3K4me3
0
10
20
30
40
Nanog HoxD4 Oct4 Suv39h2 Meisetz Jhdm2a Hdac1 Prm1
PCS
RS
H3K9me2
0
1
2
3
4
5
6
7
Nanog HoxD4 Oct4 Suv39h2 Meisetz Jhdm2a Hdac1 Prm1
PCS
RS
H3K27me3
0
5
10
15
20
25
30
Nanog HoxD4 Oct4 Suv39h2 Meisetz Jhdm2a Hdac1 Prm1
PCS
RS
TH2B
0
1
2
3
4
Nanog HoxD4 Oct4 Suv39h2 Meisetz Jhdm2a Hdac1 Prm1
PCS
RS
noAb
0
1
2
3
4
Nanog HoxD4 Oct4 Suv39h2 Meisetz Jhdm2a Hdac1 Prm1
PCS
RS
Pr
ec
ip
ita
tio
n 
re
la
tiv
e 
to
 in
pu
t (
%
) 
a 
b 
c 
d 
e 
Figure	   16:	   Occupancy	   of	   the	   histone	   modifications	   H3K4me3,	   H3K9me2,	  
H3K27me3	  and	   the	  histone	  variant	  TH2B	  at	   gene	   regulatory	   regions	   in	  PCS	  and	  
RS.	   Levels	  of	  TH2B,	  H3K9me2,	  H3K27me3	  and	  H3K4me3,	  were	  assessed	  by	  ChIP	  and	  subsequent	   q-­‐rtPCR	   for	   the	   promoters	   of	   the	   pluripotency	   genes	   Nanog,	   HoxD4	   and	  
Oct4;	   the	   histone	   methyltransferases	   Suv39h2	   and	   	  Meisetz;	   the	   histone	   demethylase	  
Jhdm2a;	  the	  histone	  deacetylase	  Hdac1;	  and	  the	  protamine	  1,	  Prm1.	  Data	  is	  presented	  as	  precipitation	   relative	   to	   input.	   a)	   TH2B	   enrichment,	   b)	   H3K9me2	   enrichment,	   c)	  H3K27me3	   enrichment,	   d)	   H3K4me3	   enrichment	   and	   e)	   enrichment	   of	   NoAb	   as	   a	  control	  of	  the	  background	  unspecific	  precipitation. 
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5.6 Correlation	  analysis	  between	  TH2B	  and	  H3K4me3,	  H3K9me2	  and	  
H3K27me3	  	  
To test whether the histone modifications H3K4me3, H3K9me2, H3K27me3 and the 
histone variant TH2B correlate with each other at the proximal promoters of Nanog, 
HoxD4, Oct4, Suv39h2, Meisetz, Jhdm2a, Hdac1 and Prm1 the Pearson correlation 
coefficient was calculated (R2). The histone variant TH2B showed a negative 
correlation with the histone modification H3K4me3 (Fig. 17a). H3K9me2 and 
H3K27me3 are described as repressive histone modifications in the literature [15] and 
there was a strong linear correlation between TH2B and  H3K9me2 (Fig. 17b). The 
same trend was seen between TH2B and H3K27me3 (Fig. 17c). In both the two 
aforementioned cases there was a stronger positive correlation between RS than PCS. 
H3K4me3 showed a negative correlation with both the repressive marks H3K9me2 
and H3K27me3 (Fig. 17d and e). The correlation between the repressive marks 
H3K9me2 and H3K27me3 was positive. In summary, TH2B associated strongly and 
significantly correlates with the repressive marks H3K9me2 and H3K27me3 at the 
tested gene promoters.  
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Figure	  17:	  Correlation	  analysis	  of	  H3K4me3,	  H3K9me2,	  H3K27me3	  and	  TH2B.	  To	  analyze	  whether	  the	  levels	  of	  H3K4me3,	  H3K9me2,	  H3K27me3	  and	  TH2B	  correlate	  with	  each	  other	  at	  the	  proximal	  promoters	  of	  Nanog,	  HoxD4,	  Oct4,	  Suv39h2,	  Meisetz,	  Jhdm2a,	  
Hdac1	  and	  Prm1	  the	  Pearson	  correlation	  coefficient	  was	  calculated	  (R2).	  In	  detail	  linear	  correlation	   was	   tested	   between	   a)	   TH2B	   and	   H3K4me3,	   b)	   TH2B	   and	   H3K9me2,	   c)	  TH2B	  and	  H3K27me3,	  d)	  H3K4me3	  and	  H3K9me2,	  e)	  H3K4me3	  and	  H3K27me3	  and	  f)	  H3K9me2	  and	  H3K27me3.	  To	  conclude	  whether	  it	   is	  a	  negative	  or	  positive	  association	  (negative	  or	  positive	  slope)	  the	  linear	  equations	  were	  plotted	  as	  well.	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5.7 Gene	  expression	  analysis	  of	  a	  pilot	  test	  panel	  of	  genes	  in	  PCS	  	  	  	  
and	  RS	  
To explore the link between analyzed histone modifications and variant with 
expression of the respective genes, we synthesized cDNA from PSC and RS and 
determined the mRNA levels for Suv39h2, Meisetz, Jhdm2a, Hdac1, Prm1 and the 
housekeeping genes Gapdh and Actb by real-time PCR. Table 10 shows cycle 
threshold (Ct) values from the real-time PCR experiment.  
The chromatin modifying enzymes Suv39h2, Meisetz, Jhdm2a and Hdac1 all showed 
significant levels of expression in both PCS and RS (Fig. 18b and table 10) and they 
all had enrichment of the histone modification H3K4me3 on their promoters (Fig. 
16d). 
The HMTase Suv39h2 and Meisetz showed increased expression upon meiotic 
progression (Fig. 18b) and the level of H3K4me3 followed this trend at the promoter 
of Meisetz but not on the Suv39h2 promoter (Fig. 16d). The level of the facultative 
repressive mark H3K9me2 (Fig. 16b) correlated with the change in expression of 
Suv39h2, as the level of H3K9me2 decreased from the PCS to the RS stage at this 
promoter  (Fig 18b). The demethylase Jhdm2a and the deacetylase Hdac1 showed 
decreased expression upon meiotic progress (Fig. 18b), while the enrichment of 
H3K4me3 increased upon progression (Fig 16d). The Prm1 gene showed relatively 
high expression, while the enrichment of H3K4me3 at this locus was low. The 
assessed repressive histone modification as well as TH2B showed quite high levels at 
the Prm1 gene  
 
Table	   10	   :	  Ct	  values	   from	  q-­‐rtPCR	  where	  cDNA	   isolated	   from	  PCS	  and	  RS	  was	  used	  as	  template.	  
Gene	   Actb	   Gapdh	   Suv39h2	   Meisetz	   Jhdm2a	   Hdac1	   Prm1	  
PCS	   24	   28	   32	   35	   27	   23	   25	  
RS	   24	   28	   29	   32	   28	   24	   22	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Figure	   18:	   mRNA	   expression	   in	   spermatogenic	   cells.	   Quantitative	   reverse	  transcription	   polymerase	   chain	   reaction	   of	   ActB,	   Gapdh,	   Suv39h2,	   Meisetz,	   Jhdm2a,	  
Hdac1,	  and	  Prm1	  a)	  The	  expression	  of	  ActB	  and	  Gapdh,	  normalized	  to	  the	  expression	  in	  PCS	   (PCS	   set	   to	   1).	   b)	   The	   expression	   of	   Suv39h2,	  Meisetz,	   Jhdm2a,	   Hdac1,	   and	   Prm1	  relative	   to	   the	  expression	  of	  Gapdh	   normalized	   to	   the	  expression	   in	  PCS	   	   (	  mean	  ±	   s.d	  from	  three	  replicates	  in	  q-­‐rtPCR).	  	  
 
 
5.8 Preparation	  of	  Chip	  DNA	  from	  spermatogenic	  cells	  for	  ChIP-­‐Seq	  
We wanted to investigate the genome-wide distribution of the histone modifications 
H3K4me3, H3K9me2, H3K27me3 and the histone variant TH2B in pachytene 
spermatocytes and round spermatids. In this context we performed ChIP, and sent our 
ChIP-DNA samples to Bejing Genomics Institute (BGI) for whole genome 
sequencing. PCS and RS isolated from five independent spermatogenic cell 
purifications (STA-PUT) were used for ChIP to ChIP-seq. The purity of the PCS and 
RS was on average 83% and 82%, respectively. The cell size was on average 11,5 µm 
for PCS and and 8,5 µm for RS. The chromatin of both cell types was sheared by 30 
cycles sonication for 30 sec and gave chromatin fragments with a major size of 200-
600bp (Fig. 19). The ChIP was performed with the antibodies H3K4me3, H3k9me2, 
H3K27me3 and TH2B. 1,5 ml or 300 µl chromatin with the concentration 0,2 A260 
where used in the ChIP-samples and input samples respectively. Before sending the 
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ChIP samples to BGI the concentration of chromatin were measured on a Qubit® 2.0 
Fluorometer (Fig. 20). To perform whole-genome sequencing it was required a DNA 
quantity above 10 ng, and all samples showed concentration above this limit. 
500 bp 
1000 bp 
3000 bp 
M PCS RS  
100 bp 
M 
 
Figure	  19:	  Fragmentation	  assessment	  of	  chromatin.	  ChIP	  chromatin	  from	  pachytene	  spermatocytes	  (PCS)	  and	  round	  spermatids	  (RS)	  was	  sheared	  by	  sonication	  30	  cycles	  for	  	  30	  s,	  yielding	  fragments	  with	  the	  sizes	  of	  200-­‐600	  bp.	  M:	  Gene	  ruler	  DNA	  ladder	  mix.	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Figure	  20:	  Total	  precipitated	  ChIP	  DNA.	  The	  quantity	  (ng)	  of	  ChIP	  DNA	  from	  PCS	  and	  RS	  was	  measured	  on	  a	  Qubit®	  2.0	  Fluorometer.	  	  
 
 
For optimum sequencing results, high quality of DNA is essential; therefore ChIP 
samples were checked for their quality by q-rtPCR prior to whole-genome 
sequencing. Each ChIP-sample was analyzed with primers for loci we know have 
high and low enrichment for each histone modification and histone variant 
(unpublished data). As expected, the H3K4me3 modification showed high enrichment 
on the Suv39h2 promoter for both PCS and RS and almost no enrichment on the 
Nanog promoter (Fig. 21a). The precipitation efficiency of H3K9me2 was 8% for 
PCS on the Nanog promoter (Fig. 21b). Due to a technical error, likely because 
template was not distributed to the relevant PCR plate wells, there was not obtained 
any results for the RS sample on this gene. At the Jhdm2a loci PCS and RS showed a 
precipitation efficiency of 0,5% and 1,4% respectively (Fig. 21b). The histone 
modification H3K27me3 showed a precipitation efficiency above 20% for both PCS 
and RS on the Hoxd4 loci and below 0,4% on the Jhdm2a loci (Fig. 21c) The Nanog 
promoter showed an enrichment of TH2B of above 2% for both PCS and RS. The 
enrichment for this histone variant was below 0,6% for both PCS and RS (Fig 21d).  
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Figure	   21:	   q-­‐rtPCR	   on	   ChIP	   samples	   for	   ChIP-­‐seq.	   ChIP	   was	   carried	   out	   with	  chromatin	   from	   PCS	   and	   RS.	   The	   precipitation	   efficiency	   of	   H3K4me3,	   H3K9me2,	  H3K27me3	  and	  TH2B	  were	  assessed	  on	  genes	  known	  to	  have	  high	  and	  low	  enrichment	  for	   each	  histone	  modification	  or	  histone	  variant.	  The	  ChIP	  experiment	  was	  performed	  with	   two	   replicates	   for	   all	   samples,	   and	   data	  were	   analyzed	   by	   duplicate	   q-­‐rtPCR	   for	  each	  replicate.	  Data	  are	  expressed	  as	  percent	  precipitation	  relative	  to	  input	  chromatin.	  Error	  bars	   indicate	  mean	  ±	   s.d.	  a)	  H3K4me3	  enrichment	  on	   the	  Nanog	  and	  Suv39h2a	  promoter.	   b)	   H3K9me2	   enrichment	   on	   the	   Nanog	   and	   Jhdm2a	   promoter.	   Due	   to	   a	  technical	   error,	   likely	   because	   template	  was	   not	   distributed	   to	   the	   relevant	   PCR	  plate	  wells,	   there	   was	   not	   obtained	   any	   results	   for	   H3K9me2	   enrichment	   for	   round	  spermatids	  for	  the	  Nanog	  promoter	  c)	  H3K27me3	  enrichment	  on	  the	  HoxD4	  promoter	  and	  Jhdm2a	  promoter.	  d)	  TH2B	  enrichment	  on	  the	  Nanog	  and	  Suv39h2a	  promoter.	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5.9 ChIP-­‐sequencing	  
Immunoprecipitated DNA from PCS and RS was sent to BGI for HiSeq sequencing to 
obtain global maps of H3K4me3, H3K9me2, H3K27me3 and TH2B. The whole-
genome ChIP sequencing was carried out with the Illumina/Solexa Genome Analyzer 
sequencing system. 
The Illumina Hiseq sequencing gave on average 38,9 millions total reads for each 
sample, (Table 11, “total reads”), and 93 – 98% of the reads could be mapped to the 
genome (Table 11, “Mapped Rate”). 
 
 
Table	   11:	   Results	   of	   reads	   alignment.	  Mapped	   reads:	   number	   of	   reads	   that	   can	   be	  aligned	   to	   reference	   genome.	   Unique	   mapped	   reads:	   number	   of	   reads	   which	   align	   to	  reference	  genome	  uniquely.	  Mapped	  rate:	  ratio	  of	  mapped	  reads	  to	  total	  reads.	  Unique	  mapped	  rate:	  ratio	  of	  unique	  mapped	  reads	  to	  total	  reads	  	  
  
Sample ID  Total 
Reads  
Mapped 
Reads  
Unique 
Mapped 
Reads  
Mapped 
Rate  
Unique 
Mapped 
Rate  
1 TH2B PCS  38933003 37507869 30165593 96.34%  77.48%  
2 TH2B PCS  38938756 37522214 30056500 96.36%  77.19%  
3 H3K4me3 PCS  38887041 37007736 33594592 95.17%  86.39%  
4 H3K4me3 PCS  38888524 36853628 33495940 94.77%  86.13%  
5 H3K9me2 PCS  38911458 37483435 28597717 96.33%  73.49%  
6 H3K9me2 PCS  38941864 37539154 28475033 96.40%  73.12%  
7 H3K27me3 PCS  38933414 36471797 26061931 93.68%  66.94%  
8 H3K27me3 PCS  38941130 36483472 25639733 93.69%  65.84%  
9 Input PCS  38813548 37672837 30124447 97.06%  77.61%  
10 TH2B RS  38949294 37473994 29579715 96.21%  75.94%  
11 TH2B RS  38949961 37490387 29672908 96.25%  76.18%  
12 H3K4me3 RS  38917299 37792522 32807465 97.11%  84.30%  
13 H3K4me3 RS  38671616 37453261 32737724 96.85%  84.66%  
14 H3K9me2 RS  38949745 37678440 29089361 96.74%  74.68%  
15 H3K9me2 RS  38932573 37724822 29417768 96.90%  75.56%  
16 H3K27me3 RS  38931263 36463143 25753499 93.66%  66.15%  
17 H3K27me3 RS  38934909 36297213 24643293 93.23%  63.29%  
18 Input RS  38919161 37699005 30043034 96.86%  77.19%  
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5.9.1 Genome-­‐wide	  peak	  scanning	  	  
In genome-wide peak scanning (Table 12) mapped reads was used to identify regions 
significantly enriched for H3K4me3, H3K9me2, H3K27me3 and TH2B. The software 
was MACS version 1.4.0, used with default settings. A limited number of peaks were 
identified for TH2B and H3K9me2 for both PCS and RS. For H3K4me3, the average 
number of peaks found was higher for RS than PCS. In contrast there was identified 
more peaks in PCS than RS for the histone modification H3K27me3.  
 
 
Table	  12:	  Result	  of	  genome-­‐wide	  peak	  scanning.	  Number	  of	  Peaks:	  the	  number	  of	  total	  peaks	  after	  peak	  calling.	  Average	  (number	  of	  peaks):	  The	  average	  of	  total	  number	  of	  peaks	  for	  replicate	  sample.	  Total	  Peaks	  Length	  (bp):	  the	  total	  length	  of	  all	  peaks.	  Average	  
(total	  peaks	  length	  (bp)):	  The	  average	  of	  total	  peaks	  length	  for	  replicate	  sample.	  
  
Sample ID  Number of 
peaks 
Average 
(number of 
peaks)  
Total Peaks 
Length (bp) 
Average 
(total peaks 
length (bp)) 
1 TH2B PCS  13 36 8541 24695 
2 TH2B PCS  58   40849   
3 H3K4me3 PCS  38645 38779 98616381 97659067 
4 H3K4me3 PCS  38912   96701752   
5 H3K9me2 PCS  81 137 58045 104304 
6 H3K9me2 PCS  192   150563   
7 H3K27me3 PCS  16887 15499 41044813 39483078 
8 H3K27me3 PCS  14111   37921343   
10 TH2B RS  53 80 38617 57497 
11 TH2B RS  106   76377   
12 H3K4me3 RS  42564 43489 121881331 121536186 
13 H3K4me3 RS  44413   121191041   
14 H3K9me2 RS  151 268 108621 196809 
15 H3K9me2 RS  385   284997   
16 H3K27me3 RS  14301 13034 38673953 33888922 
17 H3K27me3 RS  11766   29103890   	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Figure 22: Visualization of uniquely mapped reads on the Jhdm2a (Kdm3a) gene for the histone 
modification H3K4me3 in PCS. As expected it is a peak in the transcription start sight of the Jhdm2a 
gene. 	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6 DISCUSSION	  
	  
6.1 Initial	  optimization	  of	  ChIP	  assay	  
In this thesis, NCCIT cells were used for initial optimization of the ChIP-assay, as 
these cells can be easily obtained in large numbers, whereas PCS and RS are only 
available in limited amounts and require the sacrifice of mice and a cumbersome 
procedure for purification.  
Sonication of chromatin is an important step in ChIP because the size of the 
chromatin fragments influences the resolution of the ChIP assay [85]. Chromatin 
fragments that are too long will decrease resolution and may cause noise, while too 
short fragments can be unsuitable for PCR, depending on amplicon length [66]. The 
sonication step is prone to variation between researchers as minor variation in the 
probe position in the 200 µl volume in the handheld 1,5 ml tube can result in 
significant differences in fragmentation efficiency. If the probe is positioned to high, 
close to the surface, it will result in foaming and dramatically reduced fragmentation 
of chromatin. Additionally, all the time the probe is touching the wall or bottom of the 
tube during sonication it will result in energy transfer to the plastic instead of efficient 
energy transfer to the chromatin solution. As shown with decreasing DNA size as a 
result of increasing sonication exposure in figure 10, substantial practice resulted in 
highly reliable chromatin fragmentation and therefore was an important achievement 
for the further work carried out in this thesis. The ideal fragment size for q-rtPCR is 
200-1000 bp [85], and this was obtained with 10x30 sec sonication of NCCIT cells. 
Furthermore, it has previously been observed that when downscaling the starting cell 
number in ChIP the relative precipitation values increase, and this is reasoned to be 
due to an increased antibody-bead to chromatin ratio [66]. We confirmed this 
phenomenon when downscaling the cell number from 100 000 to 10 000 NCCIT cells 
(Fig. 11) in our ChIP experiments. Additionally, as expected due to increased 
stochastic variation in template amount, the standard deviation from the q-rtPCR 
increased when downscaling cell numbers. Further, it was previously observed that 
the NoAb background of unspecifically bound chromatin increases significantly when 
reducing the number of cells per ChIP. Here we overcame this problem through two 
steps providing increased stringency in the washing step of the chromatin-antibody-
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bead complexes. i) Concentrations of SDS and NaCl in the RIPA buffer was raised 
from 0,1% and 140 mM to 0,24% and 490 mM, respectively. ii) Additionally, ChIP 
samples in PCR strips were vortexed thoroughly at full speed for 5 seconds each time 
after adding fresh washing solution and prior to the standard gentle head-over-tail 
rotation for 4 min. This combination of a physically and chemically more stringent 
washing procedure gave comparable background levels despite of a 10-fold reduction 
in cell numbers. Increased signal to noise ratio in the ChIP is an important 
achievement for laying the grounds for successful ChIP-seq. 
 
 
6.2 Isolation	  and	  validation	  of	  PCS	  and	  RS	  	  
For the PCS, the size measured on the Countess® Automated Cell Counter was 
slightly lower than expected, however initial piloting experiments validated that the 
cell fraction obtained based on the reported size here mainly consisted of sex body 
containing PCS. The discrepancy between cell size measured on the Countess® 
Automated Cell Counter and that reported in the literature likely comes from the 
inaccuracy of the countess instrument. The purity of the PCS and RS was on average 
83% and 82% respectively. Based on size and staining, the remaining fraction of the 
PCS is likely leptotene, zygotene and diplotene primary spermatocytes, and the 
remaining fraction of the round spermatids is most likely early round spermatids. 
Thus, although the fractions are not 100% pure PCS or Lectin PNA- containing RS, 
the remaining fraction consists of those cells that biologically are the most similar to 
the one we have aimed to isolate. Furthermore, our purities are comparable to the best 
reports in the literature.  
 
 
 
 
 
 
	  66	  
6.3 Optimization	  of	  washing	  conditions	  for	  ChIP	  
In ChIP experiments it is desirable to achieve a high level of signal from the ChIP 
sample relative to the background signal (NoAb). A way to optimize the signal to 
noise ratio is to increase the stringency in the washing step. 
The purpose of the washing steps is to remove non-specific binding of the chromatin 
so that only the specific interactions between antibody and its target protein remain. 
Stringency of the wash solution affects the amount of nonspecific binding that is 
washed away, and it is desirable that it is so stringent that as much as possible of the 
unspecific binding is removed, but at the same time it must not be so stringent that it 
interrupts the specific binding between antibody and antigen. 
Various antibodies have different affinity for their target protein, so the stringency 
must be tested for each antibody used in a ChIP assay. In this thesis two washing 
solutions with differing degrees of stringency (RIPA-buffer with 140 mM NaCl and 
0,1% SDS and RIPA-buffer with 490 mM NaCl and 0,24% SDS) were tested in ChIP 
with the antibodies H3K4me3, H3K9me2 and TH2B. As we received the H3K27me3 
antibody used in this study after the other antibodies had already been through the 
0.1% / regular stringency RIPA buffer experiments it was tested directly in ChIPs 
with high stringency RIPA buffer (RIPA buffer with 0,24% SDS). It performed very 
well under these conditions; hence, the results did not suggest a requirement for 
further testing. For H3K4me3 there was almost no difference in precipitation 
efficiency at increased stringency. On the contrary, for the H3K9me2 antibody, the 
stringency of the washing buffer had a major impact on the precipitation efficiency as 
increased stringency resulted in a 50% decrease in the precipitation efficiency. TH2B 
showed a slightly higher precipitation efficiency when washing with the 0,1% SDS 
buffer, but the signal to noise ratio between the sample and NoAb increased with 
about 50% when increasing the stringency. The stringency testing showed that 
increased stringency affected the various antibodies differently as reflected in the 
precipitation efficiency and the enrichment at the high target gene as compared to the 
low target. 
 
 
 
	   67	  
6.4 Comparison	  of	  efficiency	  and	  specificity	  of	  ChIP	  antibodies	  	  
In ChIP analysis the antibody needs to be specific and efficient in the 
immunoprecipitation of a specific protein [85]. The affinity for epitopes differs 
between antibodies and thus affects the resulting signal levels. Also, antibodies may 
cross-react with similar eptiopes as the one they are intended to recognize. Papers that 
report the use of a specific antibody in ChIP may give a good indication of the 
suitability of an antibody, but it is important to notice that the quality of an antibody 
can differ between batches [86]. This is particularly important for polyclonal 
antibodies as different batches means that the antibodies have been raised in different 
animals and thus could perform very differently. Antibodies designated “ChIP-grade” 
or “ChIP qualified from the manufacturers also may not work successfully. Moreover, 
monoclonal and polyclonal antibodies are often available for the same epitope. A 
polyclonal antibody is derived from many different B cells, while a monoclonal 
antibody is derived from a single clone. Therefore, a polyclonal antibody population 
contains antibodies that recognize several different epitopes on the same protein or 
peptide, while a monoclonal antibody only recognize one epitope [85]. We wanted to 
identify the most promising commercially available antibodies for H3K4me3, 
H3K9me2, H3K27me3 and TH2B. The antibody used for H3K4me3 has previously 
been tested in our lab so there was no further testing required identifying this 
antibody. A monoclonal and a polyclonal H3K9me2 antibody from Diagenode were 
tested, and for the H3K27me3 modification three different antibodies were tested: a 
monoclonal and polyclonal antibody from Diagenode and a polyclonal antibody from 
Millipore. The polyclonal antibody gave the highest precipitation efficiency as 
compared to the monoclonal antibody for both H3K9me2 and H3K27me3, and this is 
consistent with the polyclonal antibody recognizing several epitopes on a protein, and 
that the combination of multiple recognition epitopes increases the likelihood of 
achieving high affinity interaction.	   The two polyclonal antibodies tested for 
H3K27me3, showed different precipitation efficiency in parallel ChIPs, indicating 
that there is a difference in the quality of the antibodies. The polyclonal antibody from 
Diagenode precipitated most chromatin, but this applied to loci with both high and 
low levels of H3K27me3. The antibody from Millipore performed better in 
distinguishing loci with high and low levels and thus gave the highest fold enrichment 
of high target relative to low target gene, so we chose to use this antibody for our 
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ChIP experiments. To our knowledge there exists only one commercial TH2B 
antibody validated for ChIP on the marked, so there was no further testing with this 
antibody. 	  
As mentioned before, in ChIP, immunoprecipitation efficiency is antibody dependent 
and the level of precipitation cannot be directly compared between different 
antibodies. Therefore, although 40% precipitation is regarded as a high level of 
precipitation for some antibodies, a precipitation level of 4% can be a high level of 
precipitation for other antibodies and thus both rates of precipitation can reflect high 
chromatin levels. 	  
 
 
 
6.5 Investigation	  of	  the	  role	  of	  TH2B,	  and	  the	  bivalent	  chromatin	  
marks	  H3K27me3	  and	  H3K4me3	  in	  spermatogenesis	  	  
Previous experiments carried out in our lab showed that the Hoxd4, Oct4 and Nanog 
genes are not expressed in PCS and RS. These aforementioned genes are all needed 
for early embryo development. We observe that there are lower levels of H3K4me3 
on Hoxd4 and Oct4 in relation to the genes that are highly expressed in PCS and RS. 
Still the level is highly significantly above background. In the light of the study of 
Hammoud et al. [51], which reported that histone proteins are retained at 
developmentally important loci in sperm, it is appealing to speculate that the bivalent 
marks we observed on Hoxd4 and Oct4 reflects epigenetic preprogramming for early 
embryo development, as an analogue to the developmentally related preprogramming 
of embryonic and somatic stem cells [62]. Histone modifications at these loci may 
therefore be subject to transgenerational inheritance. However, one can not rule out 
the possibility that these marks are erased after fertilization and rewritten in the 
embryo. Another possibility is that the observed level at Oct4 of H3K4me3 may 
reflect a previous state from when the gene was expressed in primordial germ cells 
[87]. In such a context it could be that H3K27me3 levels just have a role in repressing 
the genes throughout spermatogenesis. Moreover, in line with the lack of expression 
we also observed relatively high levels of the repressive H3K9me2 mark on the 
promoters of Nanog, HoxD4 and Oct4. A similar high occupancy was also observed 
for TH2B, which may indicate that TH2B has a repressive role. The chromatin 
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modifying enzymes encoding genes Suv39h2, Meisetz, Jhdm2a and Hdac1 all have 
detectable levels of expression for both PCS and RS. As expected their promoters all 
harbor H3K4me3 and only background levels of the H3K27me3 mark. There are 
significant differences in the expression levels in this group of genes. This variation 
can not be explained through the levels of H3K27me3 and H3K4 methylation, 
however the expression levels seems to better follow the H3K9me2 levels, in 
particular for Suv39h2a, Jhdm2a and Hdac1. Meisetz is an exception to this trend. 
Furthermore, the TH2B levels are also relatively high for the lower expressed 
Suv39h2 and Meisetz and lower for the more highly expressed Jhdm2a and Hdac1.  
Taken together, the observed levels of TH2B and H3K9me2 at the promoters of the 
developmentally related genes and chromatin modifying enzymes are indicative of 
TH2B and H3K9me2 having a relationship with gene repression in PCS and RS. 
Surprisingly, the relative highly expressed Prm1 gene harbored a low level of 
H3K4me3 and higher levels of TH2B, H3K9me2 and H3K27me3 than the other 
assessed genes which were expressed. One may speculate that the protamine gene is 
regulated differently from the other genes we analyzed and that this may be important 
for its unique biological role in the exchange of histones and chromatin packaging in 
spermatids.  
Jhdm2a and Hdac1 expression is comparable in PCS and RS. In accordance with this 
the levels of the various histone marks are also similar. Expression of Suv39h2 and 
Meisetz increase almost 10 fold from the PCS to the RS stage. This however is not 
reflected in the histone modifications and variants assessed in this study and therefore 
the regulation of these genes are likely due to other regulatory factors, perhaps 
through DNA methylation or transcription factor binding or histone modifications not 
assessed here.  
We observed that TH2B levels follow H3K9me2 levels seemingly well for all the 
genes we analyzed. Therefore correlation between these two histone marks was 
further investigated. For both PCS and RS although most strongly in RS we found 
good correlation between the repressive H3K9me2 and TH2B. This triggered a full 
analysis of the correlation between all the assessed epitopes. Also TH2B and 
H3K27me3 showed good correlations. Additionally we found negative correlation 
between TH2B and H3K4me3. Taken together, the aforementioned is supportive of 
that TH2B may have a role in testis specific gene repression. 
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6.6 Preparation	  of	  Chip	  DNA	  from	  spermatogenic	  cells	  for	  ChIP-­‐Seq	  	  
6.6.1 Sonication	  
Although sonicating extensively a lower level of higher molecular DNA was still 
present in the chromatin samples used for ChiP-seq. However, this did not affect 
resolution of the ChIP-seq experiment as only a selected lower molecular weight 
fraction of the DNA was isolated after ChIP-seq library preparation. This selection 
was performed by electrophoresis where the size fraction of 200-500 bp was sliced 
out from the gel. Only this narrow range size of the samples was subjected to 
sequencing.  
 
 
6.6.2 Technical	  aspects	  
Due to the substantial investment in time and money in ChIP-seq all ChIP samples 
and inputs were assessed for their quality by q-rtPCR prior to initiating HT-seq. To 
this end, a panel of genes shown to harbor high or low levels of the various histone 
modification or variants in our initial q-rtPCR investigation was analyzed. All ChIP 
samples showed the expected high or low enrichment of the antibody target, and they 
also showed low NoAb background levels, and therefore they were approved for 
library preparation and HT seq. 
 
6.6.3 Bioinformatic	  analysis	  of	  ChIP-­‐seq	  data	  
Illumina HiSeq successfully produced high numbers of reads that could be mapped to 
the genome. For all experiments 93-98% of the reads could be successfully mapped. 
Additionally, a high rate of sequencing reads where uniquely mapped to the genome, 
and these will be used for further analysis of localization of the histone modifications 
and the histone variant.  
In the initial round of bioinformatics analysis only a limited number of peaks were 
identified for TH2B and H3K9me2 in the genome-wide peak scanning. The reason for 
this needs to be further investigated, but it is likely that the default settings used for 
peak calling is unsuitable for analysis of TH2B and H3K9me2. We expect that	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tailored analysis settings adjusted to peak width, peak height and peak distribution for 
each of TH2B and H3K9me2 will allow for more sensitive detection of genomic loci 
with high levels of these modifications. Through discussions with researchers 
experienced in ChIP-seq analysis it is become clear to us that the analysis of many 
modifications requires adjustment of default settings.  
In contrast to a previous report from Godmann et al. 2007 [46] showing low global 
H3K4me3 levels observed by immunocytochemistry in pachytene spermatocytes, we 
only observed a slightly lower level as compared to RS. We observed a 25% lower 
genomic occupancy of H3K4me3 in PCS as compared to RS, measured by the 
number of base pairs in the genome represented in region identified as H3K4me3 
peaks (data not shown). The lower level was due to a combination of slightly reduced 
peak width and a lower number of peaks. A possible explanation of the discrepancy 
between our data and those of Godmann et al. [46] could be the difference in 
H3K4me3 antibodies used in each study. 
Additionally immunocytochemistry generally has a lower sensitivity than ChIP. One 
may also imagine that the global levels observed by Godman et al., could be due to 
chromatin binding proteins blocking the many of H3K4me3 epitopes thus making 
them unavailable to antibody binding in immunocytochemistry assays. After stringent 
lysis and then sonication procedure of ChIP chromatin, these chromatin binding 
proteins can potentially be removed and therefore the epitope become available for 
immunoprecipitation. This is an appealing explanation as H3K4me3 sites located 
outside promoters and other regulatory genomic elements have been identified as 
hotspots for double strand break related to meiotic recombination [88].  
Due to the limited time available for the work carried out for this thesis, additionally 
analysis of ChIP-Seq data will be carried out after the completion of this thesis. 
However, a preliminary glimpse into the data as shown in figure 22, which visualize 
uniquely mapped reads of DNA pulled down in two ChIP experiments, indicate 
successful ChIP and library preparation for high throughput sequencing.  
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6.7 Conclusion	  and	  outlook	  
During the progression of spermatogenesis canonical histones are replaced by histone 
variants, and at the end of spermatogenesis, most histones are replaced by protamines. 
However, it has been shown that a small fraction of histones are retained in sperm 
chromatin. Interestingly, the testis-specific histone variant TH2B has been detected at 
retained nucleosomes [51]. To date the function of TH2B is not known, but TH2B has 
been proposed to have function in chromatin organization. Our data indicate that 
TH2B may play a role as a testis specific repressive histone variant, as we observe 
good correlation with the two repressive histone modifications H3K9me2 and 
H3K27me3, and negative correlation with the activating mark H3K4me3. 
We also observed significant levels of the bivalent marks H3K4me3 and H3K27me3 
on the Hoxd4 and Oct4 promoter in PCS and RS. On a speculative note, this could 
perhaps be suggestive of preprogramming for expression in early embryo 
development. 
This work has laid the grown for extensive analysis of three histone modifications 
H3K4me3, H3K9me2, H3K27me3 and the histone variant TH2B in PCS and RS. The 
massive amount of obtained data from whole genome sequencing will likely allow for 
increased understanding of the role of the investigated histone modifications and 
variants in spermatogenesis.  
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